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Summary 
Eukaryotic cells contain several organelles that lack a delimiting membrane. 
These membrane-less organelles take over important functions within the cell and 
influence biological reactions by condensing nucleic acids and proteins into dense 
droplets. Upon environmental stress, one kind of membrane-less organelle, 
termed stress granules, assembles to sequester non-essential mRNA transcripts 
while translation is stalled. Together with RNA-binding proteins, mRNA transcripts 
form a network by multiple weak interactions within stress granules. Many RNA-
binding proteins thereby facilitate the assembly of stress granules by their low-
complexity or prion-like domains, which were identified based on their structural 
similarities with yeast prion domains. Several RNA-binding proteins that are part 
of stress granules were found aggregated in degenerative disorders. Therefore, 
stress granules have been proposed to contribute to the disease process by 
acting as nucleation sites for protein aggregates, which might evolve into 
pathological protein inclusions over time. In this study, we compared similarities 
and differences between stress granules and cytosolic prion aggregates. 
Specifically, we tested the hypothesis if recruitment of a protein with a prion-like 
domain to stress granules induces its conversion into a protein aggregate with 
self-perpetuating properties. To this end, we made use of the yeast prion domain 
NM of Sup35, expressed in mammalian cells, that can form cytosolic prions upon 
exposure to recombinant NM fibrils. Here we show that the interactome of NM 
prions significantly overlaps with that of stress granules. The presence of neither 
soluble nor aggregated NM altered the dynamics of stress granules, but stress 
granule disassembly was slightly impaired. Importantly, prolonged presence of 
stress granules did not induce NM aggregation, but rather led to cell death. 
Interestingly, chemicals that induce stress granules drastically increased NM 
aggregate formation upon concomitant induction with recombinant NM fibrils. 
However, stress granules per se were not required for the increased induction 
rate, as concomitant exposure to drugs or siRNA that interfere with stress granule 
formation did not lower the NM aggregate induction rates. We propose a model 
where stress that triggers a stress granule response results in a cellular 
environment that allows more effective protein aggregate induction by exogenous 
 Summary 
 
 
2 
seeds. One possible explanation for this is that the cellular quality control 
mechanism is overloaded under stress and thus cannot combat the additional 
aggregate induction by an exogenous seed. Therefore, the role of stress granules 
in the pathogenesis of neurodegenerative disorders might be different than so far 
anticipated. Still, triggers that cause stress granule formation enhance protein 
aggregation in the presence of exogenous seeds, thereby likely contributing to 
disease progression. 
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1. Introduction 
1.1 Membrane-less organelles 
Organizing complex biochemical reactions is essential for eukaryotic cells and 
has mainly been achieved by surrounding compartments with lipid membranes. 
These compartments restrict metabolic processes and signaling pathways to 
certain areas, thereby providing spatiotemporal control to carry out specific 
functions. However, cells have developed compartments that lack a separating 
membrane. Membrane-less organelles comprise compartments in the nucleus, 
such as nucleoli and nuclear speckles, and in the cytoplasm, such as stress 
granules (SGs) and P bodies. Consisting mainly of RNA-binding proteins (RBPs) 
and RNA, membrane-less organelles are also called ribonucleoprotein (RNP) 
granules. RNP granules fulfill numerous functions in RNA metabolism, including 
transport, storage and degradation of mRNAs (Buchan and Parker, 2009). 
Cytoplasmic RNP granules, SGs and P bodies, form from mRNAs that are not 
engaged in translation, thereby controlling mRNA translation and degradation 
(Buchan and Parker, 2009; Parker and Sheth, 2007). 
 
1.1.1 Stress granules 
SGs assemble in response to inhibition of protein synthesis due to environmental 
stress, such as heat, viral infection and oxidative conditions, or specific drugs 
(Buchan and Parker, 2009; Kedersha et al., 1999; McInerney et al., 2005). 
Inhibition of protein synthesis is achieved by phosphorylation of the α subunit of 
the translation initiation factor eIF2α at serine 51. The phosphorylation of eIF2α is 
mediated by four different kinases: the endoplasmic reticulum-resident protein 
kinase (PERK), protein kinase R (PKR), heme-regulated inhibitor (HRI) and the 
general control non-derepressible-2 (GCN2) (Jiang and Wek, 2005). Phospho-
eIF2α restricts the availability of the eIF2-GTP-tRNAiMet ternary complex, which is 
a key component of translation initiation (Hershey, 1991). The subsequent 
disassembly of polysomes leads to the active sorting of mRNAs to SGs 
(Kedersha et al., 2002; Kedersha et al., 1999). Along with untranslated mRNAs, 
SGs contain proteins involved in translation initiation (eIF4E, eIF4G, eIF4A, Papb, 
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eIF3 and eIF2) and RBPs that are involved in various aspects of mRNA 
metabolism (Anderson and Kedersha, 2006; Kedersha et al., 2002). There are 
also non-RNA-binding proteins that are part of SGs, including enzymes for 
posttranslational modifications and RNA and protein remodeling complexes, 
which play a role in SG assembly and disassembly (Jain et al., 2016). However, it 
has been shown that the composition of SGs can vary upon distinct stress stimuli 
(Aulas et al., 2017). 
 
 
 
Figure 1. Schematic diagram of stress granules. Stress granules assemble in the 
cytoplasm of mammalian cells in response to environmental stress. They consist of 
translationally repressed mRNAs and proteins, mainly RBPs, that form a network by 
multiple weak interactions. Messenger ribonucleoproteins (mRNPs) are composed of 
RBPs, such as G3BP and TIA-1, and mRNA. 
 
The first step of SG assembly is facilitated by the interaction of mRNAs and 
RBPs. Subsequently a dense network is formed by multivalent RNA-protein and 
protein-protein interactions. Overexpression of certain RBPs can lead to the 
assembly of SGs without any stress signaling present, indicating the importance 
of RBPs in the SG formation process (Gilks et al., 2004; Tourriere et al., 2003). 
Among these proteins is G3BP, a phosphorylation-dependent endoribonuclease, 
that plays a crucial role in SG assembly, as depletion of G3BP severely inhibits 
the formation of SGs (Matsuki et al., 2013). Furthermore, free mRNA is required 
for SG formation, as prevention of polysome dissociation inhibits SG assembly, 
whereas it is promoted upon disassembly of polysomes (Bounedjah et al., 2014; 
Kedersha et al., 2000). Proteins involved in SG assembly often exhibit different 
types of modular interaction domains to interact with other proteins or RNA (Shin 
and Brangwynne, 2017). Altering protein interactions by posttranslational 
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modifications, such as methylation, phosphorylation and glycosylation, can 
thereby influence SG assembly (Nott et al., 2015; Ohn et al., 2008; Tourriere et 
al., 2003). SG disassembly is facilitated in a chaperone-mediated manner, 
thereby sorting mRNAs for translation or degradation (Mateju et al., 2017; 
Wallace et al., 2015). Additionally, SGs can be cleared by autophagy, which is an 
intracellular non-selective degradation system for cytoplasmic constituents 
(Buchan et al., 2013; Mateju et al., 2017). The main function of SGs seems to be 
the translational repression, as their formation correlates with a decrease in global 
translation. However, specific mRNAs are excluded from SGs, shifting translation 
towards stress-responsive mRNAs such as heat shock proteins (Kedersha and 
Anderson, 2002). Furthermore, it has been suggested that the local concentration 
of SG components and the subsequent lower concentration of factors in the 
cytosol could influence biochemical reactions (Buchan and Parker, 2009). Thus, 
SG functions are not fully understood yet and there are many unresolved issues.  
 
1.1.2 P bodies 
Another type of RNP granule is the P body. P bodies are closely related to SGs 
and both share some components, such as specific proteins and mRNA. The 
main difference in their composition is that SGs harbor proteins involved in 
translation initiation whereas P bodies contain proteins of the mRNA decay 
machinery, for example the decapping enzymes DCP1a (decapping protein 1a) 
and DCP2 (Anderson and Kedersha, 2008). In contrast to SGs, P bodies are 
present in unstressed cells, but can be further induced in response to stress or 
inhibition of translation initiation (Kedersha et al., 2005). The functions of P bodies 
comprise mRNA degradation, translational repression and mRNA storage. During 
translational inhibition, P bodies dock onto SGs, indicating that these two 
assemblies interact with each other (Kedersha et al., 2005). Several observations 
suggest that there is an mRNA cycle between SGs, P bodies and polysomes. In 
this model mRNAs can move between these assemblies depending on their fate.  
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1.2 Role of phase separation in stress granule assembly 
SGs are highly dynamic structures, with their components being in a constant and 
rapid flux with the surrounding cytosol (Kedersha et al., 2000; Kedersha et al., 
2005). Recent studies suggest that SGs and other RNP granules assemble by a 
process known as liquid-liquid phase separation (LLPS), driven by dynamic 
protein-protein interactions (Hyman et al., 2014; Kroschwald et al., 2015; Patel et 
al., 2015). LLPS is a physical process that occurs when a mixture of molecules 
spontaneously separates into two distinct phases, a dilute and a dense phase. 
Liquid-like properties have been attributed to a number of membrane-less 
organelles, including P granules (RNP granules in embryos of Caenorhabditis 
elegans) and nucleoli (Brangwynne et al., 2009; Brangwynne et al., 2011). 
Moreover, several in vitro studies showed that mixtures of RNA and multi-domain 
proteins can phase separate into liquid droplets (Li et al., 2012; Molliex et al., 
2015; Patel et al., 2015). These findings suggest that many membrane-less 
structures have liquid-like properties and the ability to assemble by phase 
separation.  
 
Multivalent protein-protein and RNA-protein interactions are the molecular driving 
force underlying the assembly of membrane-less organelles. Different types of 
modular interaction domains and RNA-binding domains, such as RNA recognition 
motifs (RRMs), facilitate protein and RNA interactions (Shin and Brangwynne, 
2017). Furthermore, intrinsically disordered regions (IDRs), which display low 
sequence complexity and conformational heterogeneity, contribute to phase 
separation (Oldfield and Dunker, 2014). IDRs are typically enriched in polar and 
charged amino acids whilst lacking hydrophobic residues (Romero et al., 2001). 
Many IDRs contain repetitive sequences of single amino acids or short amino acid 
motifs, thus they are called low-complexity domains (LCDs). Multivalent binding 
interactions between LCD containing proteins and RNA have been shown to drive 
the assembly of liquid droplets (Li et al., 2012). Hence, it is not surprising that 
LCD containing proteins are highly enriched in the proteome of membrane-less 
organelles with a significant enrichment of LCDs in RBPs (Jain et al., 2016; King 
et al., 2012). In vitro studies showed that many RBPs, such as fused in sarcoma 
(FUS) and hnRNPA1, can undergo LLPS in a concentration dependent manner 
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(Molliex et al., 2015; Patel et al., 2015). Interestingly, liquid droplets of RBPs can 
over time turn into more gel- or solid-like structures in vitro, sometimes even into 
fibrous aggregates (Patel et al., 2015; Xiang et al., 2015).  
 
 
 
Figure 2. Two models for stress granule assembly. (A) Nucleation of translationally 
repressed mRNPs into oligomers occurs by specific, strong interactions. In the second 
step, oligomers grow by addition of mRNPs and form stable core structures. Cores fuse 
and a less dense shell is build by LLPS. (B) In the first step, mRNPs form small droplets 
by weak dynamic interactions and these phase separations grow by recruitment of 
mRNPs. Through the high local concentration of proteins with LCDs, stable core 
structures form inside the granule. (Adapted from Protter and Parker, 2016) 
 
There are two models describing the role of LLPS in the multi-phase assembly of 
SGs. SGs have been shown to consist of two distinct phases: a less concentrated 
shell, which disassembles upon cell lysis and a more stable core structure (Jain et 
al., 2016). The different models for SG assembly raise the question, which phase 
assembles first. In one model, translationally repressed mRNPs first nucleate into 
oligomers by strong, specific interactions. By recruiting additional mRNPs, 
oligomers would grow into larger assemblies, representing the SG cores. 
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Afterwards, the shell structure would form by LLPS, triggered through the high 
concentration of LCD containing proteins within the core (Jain et al., 2016; 
Wheeler et al., 2016). The second model suggests that the nucleation step is 
facilitated by LLPS of mRNPs through weak dynamic interactions. Droplets would 
grow by recruitment of more mRNPs and a core would subsequently form through 
the high concentration of LCD containing proteins (Molliex et al., 2015; Patel et 
al., 2015). 
 
1.3 RNA-binding proteins in disease 
Over the last decade, several RBPs that are part of membrane-less organelles 
have been implicated in degenerative disorders. A common feature of these 
degenerative diseases is the aggregation of RBPs in the nucleus or cytoplasm. 
An emerging hypothesis is that the pathological RBP inclusions are related to 
physiological RNP granules, indicating a disturbance in RNP granule metabolism. 
TAR DNA-binding protein of 43 kDa (TDP-43) and FUS were the first RBPs that 
were found in connection with degenerative diseases (Arai et al., 2006; Neumann 
et al., 2009; Neumann et al., 2006). Both proteins are predominantly nuclear 
proteins that harbor nucleic-acid binding domains and a LCD (Iko et al., 2004; 
Wang et al., 2004). TDP-43 was identified to be the main constituent of inclusions 
found in frontotemporal lobar degeneration (FTLD) and amyotrophic lateral 
sclerosis (ALS) (Neumann et al., 2006). In both of these diseases, TDP-43 was 
found in cytoplasmic inclusions and simultaneously cleared from the nucleus 
(Geser et al., 2009). Interestingly, TDP-43 pathology has been found in 
connection with several other degenerative disorders, including inclusion body 
myopathy, Alzheimer’s disease (AD) and Parkinson’s disease (Chen-Plotkin et al., 
2010). FUS has been identified in inclusions of several neurodegenerative 
diseases, including sporadic ALS, FTLD and Huntington’s disease (Doi et al., 
2010; Mackenzie et al., 2010; Woulfe et al., 2010). Furthermore, FUS mutations 
linked to ALS were shown to disrupt the nuclear localization and to promote 
accumulation of FUS in the cytoplasm (Dormann et al., 2010). This indicates that 
FUS and TDP-43 broadly contribute to pathology in degenerative disorders. 
Mutations in the RBP and stress granule protein TIA-1 are the cause of welander 
distal myopathy and furthermore, mutations in TIA-1 have been found in 
 Introduction 
 
 
 
9 
connection with ALS and FTLD (Hackman et al., 2013; Mackenzie et al., 2017). 
Several observations suggest that RBP positive inclusions, seen in some 
degenerative disorders, are related to SGs. TDP-43 inclusions found in ALS and 
FTLD patients colocalized with the SG markers TIA-1 and eIF3 (Liu-Yesucevitz et 
al., 2010). Furthermore, AD patient samples showed colocalization of tau 
aggregates with TIA-1 and overexpression of TIA-1 induced the formation of tau-
positive inclusions in cultured cells (Vanderweyde et al., 2012). Disease-causing 
mutations in RBPs (e.g. hnRNPA1, hnRNPA2, FUS) led to an increased 
accumulation in SGs (Bosco et al., 2010; Kim et al., 2013). Mutated SOD1 
misfolded and accumulated in SGs, thereby altering the dynamic properties of 
SGs, leading to more stable and less dynamic SGs (Mateju et al., 2017). 
Supporting these observations, in vitro studies showed that RBPs involved in ALS 
could mature from a liquid into an aberrant, solid-like state (Molliex et al., 2015; 
Patel et al., 2015). However, direct evidence that pathological inclusions are 
derived from physiological SGs is still missing. 
 
1.4 Protein misfolding disorders 
Many neurodegenerative diseases are based on the underlying mechanism that a 
natively folded protein can adopt a different, pathological conformation. This 
principle also applies to a group of rare diseases known as transmissible 
spongiform encephalopathies (TSEs). The infectious agent of TSEs is the 
misfolded form of the prion protein (PrPSc). According to the prion-hypothesis the 
infectious agent replicates in the absence of nucleic acids and by conversion of 
the natively folded protein into its pathological isoform (Bolton et al., 1982; 
Prusiner, 1982). The conversion and replication of the pathological isoform is 
thought to occur through the process of seeded polymerization (Fig. 3) (Caughey 
et al., 1995; Come et al., 1993). This model hypothesizes an equilibrium between 
the monomeric protein and an unfolded, intermediate isoform. On rare events the 
intermediate isoform can misfold into the pathological state, causing seed 
formation. Seeds can recruit monomeric protein, thereby templating the 
conversion into the misfolded isoform and leading to aggregate formation. In 
secondary nucleation events, new seeds are generated, for example by 
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fragmentation into smaller polymers that can serve as new seeds for conversion 
of monomeric protein (Knowles et al., 2009; Orgel, 1996). 
 
 
 
Figure 3. The seeded polymerization model. Seed formation occurs by conversion of 
monomeric protein into the pathological isoform via an intermediate form. The elongation 
of seeds and subsequent aggregate formation occurs by the recruitment and conversion 
of natively folded protein. Aggregates are fragmented into smaller entities that serve as 
new nucleation sites. 
 
More than 20 human diseases have been identified that share the prion principle 
of protein misfolding. This group is collectively called protein misfolding disorders 
and includes diseases such as Alzheimer’s disease, Parkinson’s disease and type 
2 diabetes (Chiti and Dobson, 2006). Many protein misfolding disorders are 
characterized by the accumulation of specific proteins into highly organized 
fibrillar aggregates. These deposits share structural characteristics as they are 
organized in a certain way. Aggregates arranged in a cross-β structure and with 
the ability to bind dyes such as Congo red and thioflavin S and T have been 
termed amyloid (Westermark et al., 2005). Amyloid fibrils have typically a 
diameter of 6-12 nm and consist of two to six protofilaments that are twisted 
around each other, forming supercoiled structures. Within the protofilaments the 
polypeptides are folded in a cross-β structure, which runs perpendicular to the 
fiber axis (Serpell, 2000; Serpell et al., 2000). Interestingly, proteins found in 
pathological aggregates do not share obvious sequence similarities (Chiti and 
Dobson, 2006). Amyloid formation is thought to follow the seeded polymerization 
mechanism, as seen for PrPSc in TSEs (Jarrett and Lansbury, 1993; O'Nuallain et 
al., 2004). One hallmark of prion diseases is that not only misfolded proteins can 
spread from cell to cell, but that the disease is transmissible between individuals. 
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For other protein misfolding disorders, recent studies have shown that protein 
aggregates are also capable of spreading from cell to cell, thereby propagating 
disease pathogenesis in a prion-like manner (Brundin et al., 2010). However, 
there are no reports of disease transmission between individuals and so far an 
infectious origin for these diseases cannot be confirmed.  
 
1.5 Prions of lower eukaryotes 
After detection of the mammalian prion protein, the prion principle was expanded 
to explain two non-Mendelian traits in Saccharomyces cerevisiae, [PSI+] and 
[URE3] (Wickner, 1994). [PSI+] and [URE3] are phenotypic traits that mimic a 
loss-of-function phenotype, yet their persistence is dependent on the expression 
of their associated genes, Sup35 and Ure2. Their phenotypes are explained by a 
prion-like mechanism, where [PSI+] and [URE3] are self-propagating 
conformations of the host encoded proteins Sup35 and Ure2 (Wickner et al., 
2001). Since the revelation that [PSI+] and [URE3] are prions, several other prions 
in lower eukaryotes have been identified, including [PIN+] and [Het-s] (Coustou et 
al., 1997; Sondheimer and Lindquist, 2000). Hence, multiple proteins in yeast can 
form prions that transmit heritable phenotypes. In contrast to the mammalian prion 
protein, yeast prions are rarely deleterious but sometimes are also advantageous 
depending on the environmental conditions (McGlinchey et al., 2011; True and 
Lindquist, 2000). The propagation of yeast prions occurs by seeded 
polymerization, similar to the mammalian prion protein. Hereby nucleus formation 
has been shown to be the rate-limiting step, while addition of exogenous seeds 
can accelerate aggregate formation in vitro (Serio et al., 2000). Fragmentation of 
prion aggregates into smaller entities is essential for maintenance and in yeast 
facilitated by the heat shock protein 104 (Hsp104) (Chernoff et al., 1995). 
Furthermore, overproduction as well as inactivation of Hsp104 can eliminate the 
prion phenotype (Chernoff et al., 1995). Inheritance of the prion state occurs by 
vertical transmission to progeny or horizontal transmission during mating (Uptain 
and Lindquist, 2002). Spontaneous conversion of the soluble into the prion 
isoform is a rare event in yeast, but once established prions faithfully propagate 
(Uptain and Lindquist, 2002). Verifying the protein-only hypothesis, in vitro 
fibrillized recombinant Sup35 is able to induce a self-propagating prion phenotype 
 Introduction 
 
 
 
12 
in yeast (King and Diaz-Avalos, 2004). Similar to the mammalian prion protein, 
yeast prions can exhibit distinct prion strains/variants that differ in mitotic stability, 
suppressor efficiency and response to the chaperone machinery (Derkatch et al., 
1996; Kushnirov et al., 2000). The distinct prion strain features are determined by 
differences in the conformation of the prion protein (Tanaka et al., 2004). The 
yeast prion behavior is encoded by prion domains (PrDs), which are enriched in 
uncharged, polar amino acids, mainly asparagine and glutamine, while lacking 
hydrophobic residues (Alberti et al., 2009; Toombs et al., 2010). Their primary 
sequence is of low complexity, intrinsically disordered and comprises typically at 
least 60 amino acids in length (Alberti et al., 2009; Toombs et al., 2010). 
However, the underlying features of prion formation are still not fully understood. 
Importantly, PrDs can be transferred to other proteins while retaining their prion 
propensities (Li and Lindquist, 2000).  
 
1.6 Prion-like domains 
RNP granules assemble through protein-protein interactions that are facilitated by 
LCDs. These domains also comprise prion-like domains (PrLDs), which were 
identified by an algorithm due to their compositional similarities to yeast prion 
domains (Alberti et al., 2009). Initially this algorithm was designed to detect prion 
candidates in the proteome of Saccaromyces cerevisiae. It is based on the prion 
domains of the known yeast prions Sup35p, Ure2p and Rnq1p, which are 
enriched for glutamine and asparagine residues (Alberti et al., 2009). Scanning 
the human proteome using the yeast prion based algorithm revealed that prion-
like regions are more common in the human proteome than previously anticipated 
(Couthouis et al., 2011). Of the human protein-coding genes, ~1% were identified 
to harbor a PrLD. Interestingly, 12% of the proteins containing a PrLD additionally 
harbor a RNA recognition motif, indicating that RBPs are especially enriched for 
PrLDs (King et al., 2012). A different algorithm assesses compositional features of 
glutamine (Q) and asparagine (N) rich regions that promote prion formation 
(Toombs et al., 2010). Many yeast prion domains show a high Q/N content, which 
is not a requirement for prion formation, but provides a high propensity for it 
(DePace et al., 1998). Subjecting the potential prion candidates among RBPs to 
the Toombs algorithm further emphasizes the aggregation-prone features of this 
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protein class, as 17 of 29 proteins passed the test and a number of others came 
close (King et al., 2012). The striking over-representation of RBPs among proteins 
with PrLDs suggests that this distinctive class of proteins is close to the edge of 
pathological aggregation. Interestingly, TDP-43 and FUS ranked in the top 10 of 
RBPs with PrLDs, suggesting a connection between prion-like propensity and 
appearance in neurodegenerative disorders. Several mutations in the PrLD of 
TDP-43 are already linked to ALS and show accelerated aggregation in vitro, 
emphasizing the involvement of PrLDs in disease pathology (Johnson et al., 
2009) 
 
 
 
Figure 4. Conversion of mutant FUS into fibrous aggregates. In vitro formed liquid 
droplets of wild type (WT) FUS and G156E FUS fused to GFP imaged over a period of 8 
hours. (Image taken from Patel et al (2015)). 
 
SGs assemble by a regulated process of protein aggregation that is facilitated by 
PrLDs of RBPs. For the SG protein TIA-1 it has been shown that it contributes to 
SG assembly by multimerization of its PrLD (Gilks et al., 2004). This indicates that 
PrLDs act as generic aggregation domains that provide proteins with the ability to 
perform essential cellular functions. However, dysfunction of proteins harboring a 
PrLD might lead to aggregation. Mutations in the PrLD or enhanced 
environmental stress might increase the likelihood for inappropriate aggregation. 
In yeast, it has already been shown that a small number of mutations is sufficient 
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to push proteins towards aggregation or even prion formation (Paul et al., 2015). 
In mammalian cells, mutations in the PrLD of TIA-1, which were identified in ALS 
and FTLD patient samples, led to a delayed SG disassembly and accumulation of 
SGs that persisted for hours (Mackenzie et al., 2017). Mutations in the PrLD of 
other RBPs also led to a higher aggregation potential in vitro and increased 
assembly of SGs, as shown for hnRNPA1 and hnRNPA2B1 (Kim et al., 2013; 
Molliex et al., 2015). For recombinant FUS it has been shown that FUS liquid 
droplets can mature over time into fibrous aggregates and that this conversion is 
accelerated by patient-derived mutations in the PrLD of FUS (Fig. 4) (Patel et al., 
2015). Hence, mutations in the PrLD of disease-associated RBPs might promote 
the formation of aggregates by accelerating the conversion of a liquid droplet into 
a fibrous state. 
 
1.7 The yeast prion Sup35 
Sup35 is one of the best-studied yeast prions so far. Its prion form [PSI+] was first 
described by Brian Cox in 1965 as a non-Mendelian factor. The normal cellular 
function of Sup35 is translation termination, whereas [PSI+] leads to the 
translational read-through of stop codons (Cox et al., 1988; Stansfield and Tuite, 
1994). Sup35 has a length of 685 amino acids while consisting of three distinct 
domains (Fig. 5).  
 
 
 
Figure 5. Primary sequence of the yeast prion Sup35. Sup35 is 685 amino acids long, 
comprising three domains: the aminoterminal N domain, the middle M domain and the 
carboxyterminal C domain. The N domain encodes the prion properties and can be 
further subdivided into a glutamine (Q) and asparagine (N) rich region (QNR), a region 
consistent of 5 1/2 oligopeptide repeats (OPR) and a carboxyterminal N domain (CTN). 
The highly charged M domain is important for solubility and stabilization during mitosis 
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and meiosis. The C domain is essential for translation termination, but dispensable for 
prion functions of the protein. Numbers refer to amino acids. 
 
The aminoterminal N domain contains the prion domain and can be further 
subdivided into three regions: a glutamine and asparagine rich region (QNR, aa 1-
39), an oligopeptide repeat region (OPR) with 5 and a half imperfect oligopeptide 
repeats (R1 – R6, aa 40-97) and a carboxyterminal N domain (CTN), which is 
also enriched in glutamine and asparagine (aa 98-123). The oligopeptide repeats 
found in the mammalian prion protein (PrP) are similar to the ones of Sup35 and a 
PrP oligopeptide repeat is able to functionally replace an oligopeptide repeat in 
Sup35 in supporting prion propagation (Parham et al., 2001). Furthermore, it has 
been shown that prion propagation is rather dependent on the amino acid 
composition of the prion domain than on the primary sequence (Toombs et al., 
2011). Scrambling of the N domain does not disrupt prion formation, further 
demonstrating an independence of the primary sequence (Ross et al., 2005). The 
middle M domain is highly charged and facilitates stabilization of [PSI+] during 
meiosis and mitosis, while increasing solubility (Liu et al., 2002). The 
carboxyterminal C domain harbors the translation termination function of Sup35, 
but is dispensable for the prion functions (Ter-Avanesyan et al., 1993). 
 
1.8 Sup35NM as a model system in mammalian cells 
Several recent studies suggest that proteins involved in pathological protein 
inclusions found in neurodegenerative diseases can spread from cell to cell in a 
prion-like manner (de Calignon et al., 2012; Goedert et al., 2010; Masuda-
Suzukake et al., 2013). Many proteins found in such inclusions are cytosolic 
proteins, thus their localization differs from that of the mammalian prion protein, 
which is membrane-anchored. In contrast to the mammalian prion protein, yeast 
prions are expressed in the cytosol. Sup35 is one of the best-studied yeast prions 
and its aminoterminal prion domain exhibits no sequence homology to 
mammalian proteins, which makes it a suitable model to study prion propagation 
in mammalian cells without a loss-of-function phenotype. Our group has 
generated a cell culture model based on the prion-forming domain NM of Sup35. 
Therefore, NM was carboxyterminally fused to a hemagglutinin-tag (HA-tag) and 
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expressed in mouse neuroblastoma N2a cells by lentiviral transduction (Krammer 
et al., 2009). Upon expression in N2a cells, NM resides in a soluble state and 
spontaneous aggregation is an extremely rare event (Duernberger et al., 2018; 
Krammer et al., 2009). Aggregate formation can be induced by the addition of in 
vitro fibrillized recombinant NM. Thereby induced NM aggregates are faithfully 
propagated to progeny (Krammer et al., 2009). The successful propagation of the 
prion state requires fragmentation of aggregates into smaller propagons, which in 
yeast is facilitated by Hsp104 (Chernoff et al., 1995). Interestingly, no mammalian 
homolog of Hsp104 exists. Hence, the fragmentation of NM aggregates in 
mammalian cells is facilitated by a different, so far unknown mechanism. Limiting 
dilution cloning of aggregate bearing cells led to the isolation of different 
aggregate types with distinct morphologically and biochemically characteristics, 
similar to yeast prion strains (Krammer et al., 2009). Sup35NM aggregates 
successfully invade neighboring cells, thereby inducing a self-perpetuating prion 
state (Hofmann et al., 2013). These results demonstrate that Sup35NM 
aggregates can faithfully propagate as a prion in mammalian cells, fulfilling all 
criteria of the life cycle of cytosolic prions (Fig. 6). 
 
 
 
Figure 6. Cytosolic prion replication cycle. (a) The prion precursor protein resides in a 
soluble state, (b) upon addition of exogenous fibrils aggregation is induced, (c) 
fragmentation of aggregates facilitates inheritance by daughter cells, (d) neighboring cells 
are invaded by propagons to induce a self-perpetuating prion state. 
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Interestingly, the subdomains driving the different steps of prion propagation differ 
between yeast and mammalian cells. In yeast, prion induction and propagation is 
facilitated by the QNR, whereas prion maintenance is mainly driven by the OPR 
(DePace et al., 1998; Osherovich et al., 2004). However, in N2a cells the last 2.5 
repeats of the OPR and the CTN are important for NM aggregate induction, prion 
formation and prion maintenance (Duernberger et al., 2018).  
 
1.9 Objective 
Membrane-less organelles are transient structures that are thought to assemble 
by liquid-liquid phase separation. These membrane-less organelles consist mainly 
of RNA and RBPs, which facilitate the assembly by forming a network of multiple 
weak interactions. RBPs often contain PrLDs, which were identified due to their 
compositional similarities to yeast prion domains and play important roles in RNP 
granule formation. Interestingly, several RBPs have already been implicated in a 
range of degenerative disorders, including FUS and TDP-43 in ALS and FTLD. 
Accumulating evidence points to a misregulation of membrane-less organelles 
and RBPs in disease, leading to the suggestion that RNP granules evolve into 
persistent, aberrant assemblies and at some point even into pathological 
aggregates (Fig. 7). However, direct evidence that physiological RNP granules 
can turn into disease-associated inclusions is still missing. Upon examination of 
the NM interactome, several SG associated proteins were identified as binding 
partners of NM and the interactomes of NM and SGs depicted a high degree of 
similarities. Aim of this study was to further investigate the correlation between 
SGs and protein aggregates, using NM expressed in mammalian cells as a 
model. The presence of prion-like domain containing proteins in SGs raised the 
question whether proteins harboring a prion domain, such as Sup35, are recruited 
to SGs and whether this recruitment could trigger the formation of a self-
perpetuating protein aggregate. To this end, NM should be stably expressed in 
the human HeLa cell line. The recruitment of SG components to NM prions and of 
soluble NM protein to SGs should be assessed. The subdomain of NM required 
for localization to SGs should be analyzed by using NM proteins with deletions in 
the N domain. FRAP analysis of SGs and NM prions should give insights about 
the dynamics of these structures and whether the presence of NM influences SG 
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dynamics. Involvement of SGs in NM aggregate induction with or without an 
exogenous seed should be analyzed by high-throughput confocal microscopy. 
Combined, this research should analyze the relationship between SGs and NM 
prions, while answering the question whether membrane-less organelles can turn 
into protein aggregates.  
 
 
 
Figure 7. RNP granules may evolve into pathological aggregates. RBPs can undergo 
phase transition and facilitate RNP granule formation through transient interactions of 
their PrLDs. By bringing RBPs into close proximity in RNP granules, persistence of these 
granules might lead to misfolding. Eventually these persistent granules can give rise to 
pathological fibrillar aggregates as observed in neurodegenerative disorders. (Adapted 
from March et al., 2016) 
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2. Materials and methods 
2.1 Biological safety 
The work with genetically modified organisms and genetic engineering was 
performed under biosafety level 2 according to the German Gentechnikgesetz 
(August 31st, 2015). All contaminated materials and solutions were collected, 
inactivated and disposed following the official regulations. 
 
2.2 Chemicals 
All chemicals were purchased from Sigma-Aldrich (Steinheim, Germany) or Carl 
Roth (Karlsruhe, Germany), unless stated otherwise. 
 
2.3 Cell culture 
Cell culture was performed under sterile conditions in a laminar flow cabinet using 
sterile medium, glass and plastic ware. Cells were cultured in a CO2 incubator 
(HERAcell 240i, Thermo Fisher Scientific, Waltham, USA) at 37°C with 5 % CO2 
in a humidified atmosphere. 
 
2.3.1 Thawing of cells 
Culture medium    Dulbecco’s Modified Eagle Medium  
(DMEM) + GlutaMAX (Gibco, Waltham, 
USA) 
      + 10 % fetal calf serum (FCS)  
(Biochrom, Berlin, Germany) 
 
Cells stored in liquid nitrogen were thawed at 37°C and resuspended in culture 
medium. Cell suspension was centrifuged at 300 x g for 5 min at room 
temperature (RT) (Heraeus Multifuge X3R, Thermo Fisher Scientific, Waltham 
USA). The cell pellet was resuspended in culture medium and transferred to a cell 
culture flask. 
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2.3.2 Culturing of cells 
Phosphate buffered saline (PBS)  Gibco, Waltham, USA 
Trypsin-EDTA, 0.25 %   Gibco, Waltham, USA 
 
Cells were grown in cell culture flasks or dishes and passaged every 2-3 days. 
For passaging, cells were rinsed once with PBS and detached by incubation with 
Trypsin-EDTA for 5 min at RT. Inactivation of Trypsin was achieved by adding at 
least one volume of fresh culture medium. After resuspension, cells were 
centrifuged at 300 x g for 5 min at RT (Heraeus Multifuge X3R, Thermo Fisher 
Scientific, Waltham USA). The supernatant was discarded and the pellet 
resuspended in culture medium. The cell suspension was plated into new flasks 
or dishes containing culture medium. For determination of cell numbers an 
automated cell counter was used (TC 20, BioRAD, Hercules, USA). 
 
Table 1: Cell lines 
Cell line Property Reference 
N2a 
Murine neuroblastoma 
cell line 
ATCC CCL-131 
HeLa 
Human cervix epitheloid 
carcinoma cell line 
93021013 ECACC 
HeLa NM-HA 
HeLa cells expressing 
NM-HA 
Generated in this study 
HeLa NM-HAagg 
HeLa cells producing 
NM-HA aggregates 
Generated in this study 
HeLa NM-GFP 
HeLa cells expressing 
NM-GFP 
Generated in this study 
HeLa G3BP1-mCherry 
HeLa cells expressing 
G3BP1-mCherry (BAC) 
Kindly provided by 
Simon Alberti 
HeLa G3BP1-mCherry 
NM-GFP 
HeLa cells expressing 
G3BP1-mCherry (BAC) 
and NM-GFP 
Generated in this study 
HeLa NM-HA ∆ 1-39 
HeLa cells expressing 
NM-HA ∆ 1-39 
Generated in this study 
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HeLa NM-HA ∆ 39-57 
HeLa cells expressing 
NM-HA ∆ 39-57 
Generated in this study 
HeLa NM-HA ∆ 39-74 
HeLa cells expressing 
NM-HA ∆ 39-74 
Generated in this study 
HeLa NM-HA ∆ 75-97 
HeLa cells expressing 
NM-HA ∆ 75-97 
Generated in this study 
HeLa NM-HA ∆ 75-123 
HeLa cells expressing 
NM-HA ∆ 75-123 
Generated in this study 
HeLa NM-HA ∆ 98-123 
HeLa cells expressing 
NM-HA ∆ 98-123 
Generated in this study 
 
2.3.3 Cryoconservation of cells 
Freezing medium    FCS (Biochrom, Berlin, Germany)  
+ 10 % Dimethyl sulfoxide (DMSO) 
 
Cryoconservation of cells in liquid nitrogen was used for long-term storage of 
cells. Cells were detached as described (2.3.2) and pelleted at 300 x g for 5 min 
at 4°C (Heraeus Multifuge X3R, Thermo Fisher Scientific, Waltham, USA). Cell 
pellets were resuspended in freezing medium and transferred to cryogenic vials. 
Vials were kept at -80°C overnight and subsequently transferred to liquid nitrogen. 
2.3.4 Lentiviral transduction of mammalian cells 
Transduction medium   5 % FCS (Biochrom, Berlin, Germany) 
      8 µg/ml Polybrene (Merck Millipore, 
Billerica, USA) 
      in DMEM (Gibco, Waltham, USA) 
 
For transduction, 2x104 cells per well were plated on a 24-well plate. The next day 
culture medium was replaced with transduction medium and the appropriate 
amount of lentiviral particles was added to the cells (Table 2). Viral particles were 
kindly provided by Yvonne Dürnberger (Duernberger et al., 2018) .The 24-well 
plate was centrifuged at 800 x g for 10 min at RT (Heraeus Multifuge X3R, 
Thermo Fisher Scientific, Waltham, USA). After 24 h of culturing, the medium was 
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exchanged with fresh culture medium. Cells were expanded to generate stable 
cell lines and aliquots were frozen in liquid nitrogen (2.3.3). 
 
Table 2: Expression plasmids of viral particles 
Construct Reference 
pRRL.sin.PPT.CMV. 
NM-HA.Wpre 
Duernberger et al. (2018) 
pRRL.sin.PPT.CMV. 
 NM-GFP.Wpre 
Duernberger et al. (2018) 
pRRL.sin.PPT.CMV. 
NM-HA ∆ 1-39.Wpre 
Duernberger et al. (2018) 
pRRL.sin.PPT.CMV. 
NM-HA ∆ 39-57.Wpre 
Duernberger et al. (2018) 
pRRL.sin.PPT.CMV. 
NM-HA ∆ 39-74.Wpre 
Duernberger et al. (2018) 
pRRL.sin.PPT.CMV. 
NM-HA ∆ 75-97.Wpre 
Duernberger et al. (2018) 
pRRL.sin.PPT.CMV. 
NM-HA ∆ 75-123.Wpre 
Duernberger et al. (2018) 
pRRL.sin.PPT.CMV. 
NM-HA ∆ 98-123.Wpre 
Duernberger et al. (2018) 
 
2.3.5 Aggregate induction by recombinant NM fibrils 
Recombinant NM protein (prepared as described in 2.4.8) was rotated head-over-
tail at 50 rpm for 24 h at 4°C (LD-76, Labinco, DG Breda, Netherlands) at a 
concentration of 100 µM (monomer concentration) to generate fibrils. To break 
fibrils into smaller entities, fibrils were sonicated for 3 min (5 sec on, 1 sec off) with 
10 % amplitude (Sonicator Sonoplus, Bandelin, Berlin, Germany) in an ice-cold 
water bath. Fibrils were added to cells at a final concentration of 5 µM (monomer 
concentration). 
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2.3.6 Generation of HeLa NM-HAagg cell line  
To generate a cell line that stably carries NM aggregates, limiting dilution cloning 
was conducted using HeLa NM-HA expressing cells that were subjected to 
aggregate induction (2.3.5). Cells were detached and the cell number was 
determined as described before (2.3.2). Cells were plated on 96-well plates at a 
concentration of 10 cells/ml (100 µl/well). After approximately 10 days of culturing, 
single cell clones were selected and further expanded. Cell clones were subjected 
to immunofluorescence staining and microscopy analysis (2.3.14) to detect NM 
aggregate bearing cells. Six cell clones were selected and mixed at equal cell 
numbers to generate a bulk cell line (HeLa NM-HAagg). Cells were expanded and 
aliquots were frozen in liquid nitrogen (2.3.3). 
2.3.7 Live cell imaging 
Cells were plated on 35 mm µ-Dishes or 4-well µ-Slides (Ibidi, Madison, USA) and 
cultured overnight. Time-lapse images were taken over the indicated periods of 
time using an widefield fluorescence microscope (Zeiss, Jena, Germany) at 37°C 
and 5 % CO2. For imaging of aggregate inheritance, cells were subjected to 
aggregate induction (2.3.5) 48 h prior to imaging and time-lapse images were 
taken over a period of 16 h with a time interval of 5 min. Cells imaged for 
aggregate induction were incubated with 75 µM sodium arsenite for 30 min before 
5 µM recombinant NM fibrils (monomer concentration) were added. Subsequently 
cells were imaged for 22 h with a time interval of 10 min. For stress granule (SG) 
assembly and disassembly, cells were treated with 500 µM (SG assembly) or 250 
µM (SG disassembly) sodium arsenite and either directly subjected to imaging (60 
min, 1 min interval) or incubated for 1 h, followed by two washing steps before 
imaging (3 h, 2 min interval).  
2.3.8 Coculture analysis 
HeLa NM-HAagg or HeLa NM-HAsol donor cells were cocultured with HeLa NM-
GFPsol recipient cells at a ratio of 1.5:1 on coverslips (4x104 total cells). After 48 h, 
cells were fixed and stained as described (2.3.14). Images were taken using a 
LSM 700 confocal microscope (Zeiss, Jena, Germany). 
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2.3.9 Stress granule induction 
For stress granule induction cells were plated on coverslips and cultured 
overnight. To induce stress granules, cells were exposed to either 500 µM sodium 
arsenite for 1 h, 100 µM MG132 for 2 h, 200 mM NaCl for 1 h, heat shock at 45°C 
for 30 min or cells were transfected with either 300 ng high molecular weight 
(HMW) dsRNA (InvivoGen, San Diego, USA) or 300 ng low molecular weight 
(LMW) dsRNA (InvivoGen, San Diego, USA) using Lipofectamine 2000 
transfection reagent (Thermo Fisher Scientific, Waltham, USA). Cells were 
subsequently fixed and immunofluorescence staining was performed as described 
(2.3.14). Images were taken using a LSM 700 confocal microscope (Zeiss, Jena, 
Germany). 
2.3.10 Stress treatment 
Microplate, 96-well, µ-clear,  Greiner Bio-One, Kremsmünster, Austria 
   F-Bottom, black 
 
Cells were plated on 96-well plates (6x103 cells/well) or 12-well plates (2x105 
cells/well) and grown for 24 h. 30 min prior to the respective treatment the 
medium was replaced with fresh, pre-warmed culture medium. Compounds were 
added at the indicated concentrations (Table 3) or cells were subjected to heat 
shock at 44°C and after 1 h 5 µM recombinant NM fibrils (monomer concentration) 
were added or cells were left untreated. After 1 h, cells were washed once with 
pre-warmed culture medium and fresh culture medium was added. Cells were 
cultured for 16 h, subsequently fixed and stained as described (2.3.15). For SG 
induction control experiments, 8x103 cells/well were plated on 96-well plates, fixed 
2 h after addition of compounds and subjected to immunofluorescence staining 
(2.3.15). For detection of phosphorylated eIF2α, cells were harvested 1 h and 2 h 
after addition of compounds and processed as described (2.3.2 and 2.4.1). 
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Table 3: Stress treatment compounds 
Compound Concentration Reference 
Sodium arsenite 250 µM 
Sigma-Aldrich, 
Steinheim, Germany 
NaCl 200 mM 
Carl Roth, Karlsruhe. 
Germany 
Cycloheximide 20 µg/ml 
Sigma-Aldrich, 
Steinheim, Germany 
Puromycin 10 µg/ml 
Sigma-Aldrich, 
Steinheim, Germany 
MG132 20 µM 
Merck Millipore, 
Billerica, USA 
Tunicamycin 5 µg/ml 
Sigma-Aldrich, 
Steinheim, Germany 
Thapsigargin 0.5 µg/ml 
Merck Millipore, 
Billerica, USA 
Salubrinal 50 µM 
Sigma-Aldrich, 
Steinheim, Germany 
Rapamycin 10 µM 
Merck Millipore, 
Billerica, USA 
Wortmannin 10 µM 
Selleckchem, Munich, 
Germany 
 
2.3.11 siRNA Transfection 
Lipofectamine RNAiMAX    Thermo Fisher Scientific, Waltham, USA 
   Transfection Reagent 
 
Cells were plated on 24- or 6-well plates and cultured overnight. The following 
day, cells were subjected to transfection according to the manufacturer’s 
instructions. Knockdown efficiency was tested every time by western blotting 
(2.4.7). 
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2.3.12 Plasmid Transfection 
Lipofectamine 2000    Thermo Fisher Scientific, Waltham, USA 
   Transfection Reagent 
 
Cells were plated on 24-well plates and cultured overnight. The following day, 
cells were subjected to transfection according to the manufacturer’s instructions. 
For immunofluorescence staining cells were detached after 24 h, plated on 
coverslips and fixed on the next day. Immunofluorescence staining was 
performed as described (2.3.14). 
 
Table 4: Plasmids 
Construct Tag Vector Backbone Reference 
VCP EGFP pEGFP-N1 
Gift from Nico Dantuma 
(Addgene # 23971) 
Keap1 GFP phrGFP-N1 
Gift from Qing Zhong 
(Addgene # 28025) 
hPLIC-2 FLAG pCMV4 
Gift from Peter Howley 
(Addgene # 8661) 
 
2.3.13 Fluorescent recovery after photobleaching (FRAP) analysis 
FRAP analysis was performed using a LSM 710 or LSM 700 confocal microscope 
(Zeiss, Jena, Germany). Cells were plated on 35 mm µ-Dishes (Ibidi, Madison, 
USA) and grown overnight. For FRAP analysis of SGs, cells were treated with 0.5 
mM sodium arsenite 30 min prior to photobleaching. A single SG was bleached 
with high power of the 405 nm laser and fluorescence recovery was analyzed for 
60 sec. For FRAP analysis of NM prions, cells were exposed to 5 µM recombinant 
fibrils (monomer concentrations) 48 h prior to photobleaching. NM prions were 
partially bleached with high power of the 405 nm laser and fluorescence recovery 
was analyzed for 4 min. Data processing was carried out using Fiji analysis 
software. Background was determined outside the fluorescently labeled cells and 
subtracted. The ratio of fluorescence intensity of the photobleached region of 
interest (ROI) to that of a neighboring cell was calculated for each time point 
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[F(t)ROI/F(t)cell] to correct for photodamage. Fluorescent intensities were 
normalized to the prebleach intensity. 
2.3.14 Immunofluorescent staining for confocal microscopy analysis 
High Precision Microscope   Marienfeld Superior, Lauda-Königshofen, 
   Cover Glass, No 1.5H   Germany 
Aqua Polymount    Polysciences, Warrington, USA 
Superfrost Plus Microscopic Slides Thermo Fisher Scientific, Waltham, USA 
Hoechst 33342    Molecular Probes, Eugene, USA 
Permeabilization solution   0.1 % Triton X-100 (Carl Roth, Karlsruhe, 
Germany) in PBS 
Blocking solution    2 % goat serum (Dianova,  
Hamburg, Germany) in PBS 
Blocking solution (for primary  2 % donkey serum (Dianova, 
   antibodies produced in goat)  Hamburg, Germany) in PBS 
 
For immunofluorescence staining, cells were grown on coverslips in 24-well plates 
for at least 24 h. Cells were treated according to the individual experiments and 
subsequently fixed with 4 % paraformaldehyde (in PBS) for 10 min at RT. After 
rinsing the cells three times with PBS, cells were incubated with permeabilization 
solution for 10 min at RT. Following three washing steps with PBS, cells were 
incubated with blocking solution for 1 h at RT. Specific proteins were visualized by 
incubation with the respective primary antibodies diluted in blocking solution 
overnight at 4°C in a humidified chamber (Table 5). Cells were washed three 
times with PBS for 5 min to remove unbound antibody and were subsequently 
incubated with the appropriate fluorophore-coupled secondary antibodies in 
blocking solution for 1 h at RT (Table 6). Following three washing steps with PBS 
for 5 min, nuclei were stained with Hoechst 33342 (1 µg/ml in PBS) for 5 min at 
RT. Cells were washed four times with PBS and coverslips were dipped once in 
H2Obidest before they were mounted on microscopic slides using Aqua Polymount. 
Confocal microscopy was performed using a LSM 700 (Zeiss, Jena, Germany). 
For superresolution imaging, a LSM 800 with Airyscan (Zeiss, Jena, Germany) 
was used. 
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Table 5: Primary antibodies 
Antibody Origin Specificity Dilution Reference 
Anti-
hemagglutinin  
F7 
Mouse 
monoclonal 
Epitope of 
hemagglutinin 
(YPYDVPDYA) 
IF 
1:200 
Santa Cruz 
Biotechnology, 
Santa Cruz, USA 
Anti-
hemagglutinin  
3F10 
Rat 
monoclonal 
Epitope of 
hemagglutinin 
(YPYDVPDYA) 
WB 
1:1000 
Roche 
Diagnostics, 
Basel, 
Switzerland 
Anti-
hemagglutinin 
Alexa-647 
Mouse 
monoclonal 
Epitope of 
hemagglutinin 
(YPYDVPDYA) 
IF 
1:500 
Biozol, Eching, 
Germany 
Anti-actin C4 
Mouse 
monoclonal 
Chicken gizzard 
actin, all six 
known vertebrate 
isoactins 
WB 
1:5000 
MP Biomedicals, 
Eschwede, 
Germany 
Anti-G3BP 
Rabbit 
monoclonal 
Residues within 
Human G3BP aa 
400 to the C-
terminus 
IF 1:500 
WB 
1:5000 
IP  
0.4 µg/ml 
Abcam, 
Cambridge, UK 
Anti-TIA-1  
C-20 
Goat 
polyclonal 
Residues near 
the C-terminus of 
human TIA-1 
IF 1:250 
WB 1:250 
Santa Cruz 
Biotechnology, 
Santa Cruz, USA 
Anti-TIA-1 
Rabbit 
monoclonal 
Residues within 
aa 350 to the C-
terminus 
IP  
3 µg/ml 
Abcam, 
Cambridge, UK 
Anti-TIAR 
Rabbit 
monoclonal 
Residues near 
the C-terminus of 
human TIAR 
IF 1:500 
Cell Signaling 
Technology, 
Danvers, USA 
Anti-Dcp1a 
Rabbit 
polyclonal 
Residues within 
aa 300-400 of 
Human Dcp1a 
IF 1:250 
Abcam, 
Cambridge, UK 
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Anti-G3BP 
Alexa-568 
Rabbit 
monoclonal 
Residues within 
Human G3BP aa 
400 to the C-
terminus 
IF 1:500 
Abcam, 
Cambridge, UK 
Anti-FMRP 
Rabbit 
polyclonal 
Residues 550 to 
the C-terminus of 
Human FMRP 
IF 1:250 
Abcam, 
Cambridge, UK 
Anti-phospho 
eIF2α 
Rabbit 
polyclonal 
 eIF2α 
phosphorylated 
on Serine 51 
WB 
1:1000 
Cell Signaling 
Technology, 
Danvers, USA 
Anti- eIF2α 
Rabbit 
polyclonal 
Residues in the 
C-terminus of 
eIF2α 
WB 
1:1000 
Cell Signaling 
Technology, 
Danvers, USA 
Anti-phospho 
EIF2S1 
Rabbit 
monoclonal 
EIF2S1 
phosphorylated 
on Serine 51 
WB 
1:1000 
Abcam, 
Cambridge, UK 
Anti-EIF2S1 
Mouse 
monoclonal 
Recombinant full 
length protein 
WB 
1:1000 
Abcam, 
Cambridge, UK 
Anti-LC3A/B 
(D3U4C) 
Rabbit 
monoclonal 
Residues 
surrounding 
Leu44 of human 
LC3B protein 
WB 
1:1000 
Cell Signaling 
Technology, 
Danvers, USA 
Anti-p62 
Rabbit 
monoclonal 
Residues within 
Human p62 aa 
400-500 
IF 1:500 
WB 
1:5000 
Abcam, 
Cambridge, UK 
Anti-FLAG 
M2 
Mouse 
monoclonal 
Epitope of FLAG 
(DYKDDDDK) 
IF 1:500 
Sigma-Aldrich, 
Steinheim, 
Germany 
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Table 6:Secondary antibodies 
Antibody Origin Specificity Dilution Reference 
Horseradish 
peroxidase 
(HRP) conj. anti-
rat IgG 
Goat Rat IgG 1:10.000 
Dianova, 
Hamburg, 
Germany 
Horseradish 
peroxidase 
(HRP) conj. anti-
mouse IgG 
Goat Mouse IgG 1:10.000 
Dianova, 
Hamburg, 
Germany 
Horseradish 
peroxidase 
(HRP) conj. anti-
rabbit IgG 
Goat Rabbit IgG 1:10.000 
Dianova, 
Hamburg, 
Germany 
Horseradish 
peroxidase 
(HRP) conj. anti-
goat IgG 
Rabbit Goat IgG 1:10.000 
Dianova, 
Hamburg, 
Germany 
Alexa Fluor 488-
conj. anti-mouse 
Goat Mouse IgG 1:500 
Life Technologies, 
Darmstadt, 
Germany 
Alexa Fluor 488-
conj. anti-mouse 
Donkey Mouse IgG 1:500 
Life Technologies, 
Darmstadt, 
Germany 
Alexa Fluor 568-
conj. anti-rabbit 
Goat Rabbit IgG 1:500 
Life Technologies, 
Darmstadt, 
Germany 
Alexa Fluor 568-
conj. anti-mouse 
Donkey Mouse IgG 1:500 
Life Technologies, 
Darmstadt, 
Germany 
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Alexa Fluor 568-
conj. anti-goat 
Donkey Goat IgG 1:500 
Life Technologies, 
Darmstadt, 
Germany 
Alexa Fluor 647-
conj. anti-goat 
Donkey Goat IgG 1:500 
Life Technologies, 
Darmstadt, 
Germany 
 
2.3.15 Immunofluorescence staining for automated microscopy analysis 
Microplate, 96-well, µ-clear,  Greiner Bio-One, Kremsmünster, Austria 
   F-Bottom, black 
HCS CellMask Blue Stain   Molecular Probes, Eugene, USA 
Hoechst 33342    Molecular Probes, Eugene, USA 
Permeabilization solution   0.5 % Triton X-100 (Carl Roth, Karlsruhe, 
Germany) in PBS 
Blocking solution    2 % goat serum (Dianova,  
Hamburg, Germany) in PBS 
 
For automated microscopy analysis cells were seeded on 96-well plates and 
grown for at least 24 h. After the indicated treatment, cells were fixed by adding 8 
% paraformaldehyde directly into the medium (final concentration: 4 %) and 
incubated for 15 min at RT. Cells were washed with PBS three times and 
permeabilization solution was added for 10 min at RT. Following three washing 
steps with PBS, cells were blocked with 2 % goat serum for 1 h at RT. Primary 
antibodies were added at the indicated dilutions and incubated for 2 h at RT 
(Table 5). In case of unlabeled primary antibodies, cells were washed three times 
for 5 min with PBS and incubated with the respective fluorophore-coupled 
secondary antibodies for 1 h at RT (Table 6). Nuclei and cytoplasm were stained 
with Hoechst 33342 (1 µg/ml) and CellMask (1:2500) for 10 min at RT. Cells were 
washed once with PBS and either directly analyzed or stored at 4°C until imaging. 
For analysis the automatic confocal microscope Cell Voyager 6000 (Yokogawa, 
Tokyo, Japan) was used.  
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2.3.16 RNA Staining 
SYTO RNASelect Green   Thermo Fisher Scientific, Waltham, USA 
   fluorescent cell stain  
 
For staining of RNA, cells were plated on coverslips in a 24-well plate and grown 
for at least 24 h. Cells were either subjected to stress granule induction (2.3.9) or 
left untreated. SYTO RNASelect was added to the culture medium at a 
concentration of 1 µM and cells were incubated for 20 min at 37°C. Subsequently, 
cells were rinsed two times with PBS and fixed with ice-cold methanol for 10 min 
at -20°C. Immunofluorescence staining was performed as described (2.3.14). 
2.3.17 Detection of autophagy 
Cells were plated in 12-well plates and grown for 6 h. To detect induction of 
autophagy, the drug chloroquine was used. Chloroquine inhibits the fusion of 
autophagosomes with lysosomes, leading to the accumulation of autophagy 
markers, such as LC3-II and p62. Chloroquine and H2O, as the respective control, 
were added to the cells at a final concentration of 10 µM. After 16 h cells were 
harvested and lysed as described (2.3.2 and 2.4.1). Samples were analyzed for 
autophagy markers via western blot (2.4.3 und 2.4.7). 
 
2.4 Protein biochemical methods 
2.4.1 Preparation of protein lysates from mammalian cells 
Lysis buffer     150 mM NaCl 
      50 mM Tris/HCl, pH 7.5 
      1 % NP-40 
      in H2Obidest 
      Protease inhibitor (complete, EDTA free,  
Roche Diagnostics, Basel, Switzerland) 
 
Cells were harvested as described (2.3.2) and centrifuged at 300 x g for 5 min at 
4°C (Eppendorf Centrifuge 5417R, Hamburg, Germany). Cell pellets were 
resuspended in PBS and centrifuged as before. Pellets were resuspended in an 
appropriate amount of lysis buffer and incubated on ice for 30 min. Cell debris 
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was spun down at 514 x g for 4 min at 4°C (Eppendorf Centrifuge 5417R, 
Hamburg, Germany) and supernatant was transferred to a fresh tube. Samples 
were either used directly or stored at -20°C. 
2.4.2 Bradford protein assay 
Quick Start Bradford Assay  BioRAD, Hercules, USA 
Quick Start Bovine Serum Albumin BioRAD, Hercules, USA 
   Standard Set 
 
The Bradford protein assay was used to determine the protein concentration of 
cell lysates. Lysates were diluted 1:10 in H2Obidest and 5 µl were transferred in 
duplicates to a clear 96-well plate. A BSA standard dilution series (62.5 - 2000 
µg/ml) and a H2O blank control were added to the plate. 250 µl Bradford reagent 
were added to each well and incubated for 5 min at RT. The absorbance was 
measured at 595 nm with a plate reader (FLUOstar Omega, BMG Labtech, 
Offenburg, Germany). MARS data analysis software was used to calculate protein 
concentrations. 
2.4.3 Discontinuous sodium dodecyl sulfate - polyacrylamide gel 
electrophoresis (SDS-PAGE) 
3x Sample buffer    90 mM Tris/HCl, pH 6.8 
      7 % SDS 
      30 % Glycerol 
      20 % β-Mercaptoethanol 
      0.01 % Bromphenol blue 
      in H2Obidest 
10x Tris/Glycine/SDS Electrophoresis 250 mM Tris 
   buffer (BioRAD, Hercules, USA) 1.92 M Glycine 
      1 % SDS 
      pH 6.8 
Any kD Mini-PROTEAN TGX  BioRAD, Hercules, USA 
   Precast Gels 
Any kD CRITERION TGX   BioRAD, Hercules, USA 
   Precast Gels 
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4-20 % Mini-PROTEAN TGX  BioRAD, Hercules, USA 
   Precast Gels 
PageRuler Plus Prestained  Thermo Fisher Scientific, Waltham, USA 
   Protein Ladder 
InstantBlue Protein Stain   C.B.S Scientific, San Diego, USA 
 
SDS-PAGE is a method to separate proteins according to their size. The any kD 
precast gels from BioRAD were used for all experiments, except for detection of 
autophagy, where the 4-20% precast gels (BioRAD) were used. Protein samples 
were mixed with 3x sample buffer and heated for 5 min at 95°C. Samples and 4 µl 
of protein ladder were loaded onto the gel and run at 20 mA (Mini PROTEAN 
gels) or at 30 mA (CRITERION gels) for 1.5 h. Gels were further used for western 
blotting or stained with InstantBlue for 30 min to directly detect proteins. 
2.4.4 Immunoprecipitation  
Lysis Buffer     50 mM Tris/HCl, pH 7.5 
      150 mM NaCl 
      1 % NP-40 
      Protease inhibitor (complete, EDTA free, 
Roche Diagnostics, Basel, Switzerland) 
      in H2Obidest 
 
Cells cultured in 10 cm dishes were harvested and lysed as described (2.3.2 and 
2.4.1). Protein concentration was determined via Bradford assay (2.4.2) and 
samples were adjusted to comparable protein concentrations. As control, protein 
extract samples for western blotting were prepared as described (2.4.3). Specific 
antibodies (Table 5) were added at the indicated concentrations and samples 
were incubated overnight at 4°C, on a rotating wheel. On the following day, 10 µl 
magnetic beads (Dynabeads, Thermo Fisher Scientific, Waltham, USA) were 
added and samples were rotated for 1 h at 4°C. Samples were placed in a 
magnetic rack (Thermo Fisher Scientific, Waltham, USA) and captured protein 
complexes were washed five times with lysis buffer. Beads were resuspended in 
3x sample buffer and boiled for 5 min at 95°C. Using the magnetic rack, bead-free 
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samples were transferred to fresh tubes. Samples were either stored at -20°C or 
used directly for SDS-PAGE (2.4.3) and western blot analysis (2.4.7). 
2.4.5 Sedimentation assay 
Lysis Buffer     10 mM Tris/HCl, pH 7.5 
      100 mM NaCl 
      10 mM EDTA 
      0.5 % Triton X-100 
      0.5 % sodium deoxycholate 
      Protease inhibitor (complete, EDTA free, 
Roche Diagnostics, Basel, Switzerland) 
      in H2Obidest 
TNE Buffer     50 mM Tris/HCl, pH 7.5 
      150 mM NaCl 
      5 mM EDTA 
      in H2Obidest 
 
Cells were plated on 6 cm dishes, grown overnight and harvested as described 
(2.3.2). Pellets were resuspended in lysis buffer and incubated on ice for 30 min. 
Cell debris was removed by centrifugation at 1000 x g for 1 min at 4°C (Eppendorf 
Centrifuge 5417R, Hamburg, Germany). The supernatant was transferred to a 
fresh tube and centrifuged at 20.000 x g for 20 min at 4°C to separate the soluble 
from the insoluble fraction. The pellet containing the insoluble fraction was 
resuspended in TNE buffer. Proteins in the soluble fraction were precipitated with 
four volumes of methanol overnight at -20°C. Samples were centrifuged at 2100 x 
g for 25 min at 4°C and pellets were resuspended in TNE buffer. Samples were 
prepared for SDS-PAGE and western blotting as described (2.4.3 and 2.4.7). To 
detect NM in the insoluble fraction, 10x more of the insoluble fraction was loaded 
compared to the soluble fraction. 
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2.4.6 Semi-denaturing detergent – agarose gel electrophoresis (SDD-AGE) 
Lysis buffer     150 mM NaCl 
      50 mM Tris/HCl, pH 7.5 
      1 % NP-40 
      in H2Obidest 
      Protease inhibitor (complete, EDTA free,  
Roche Diagnostics, Basel, Switzerland) 
4x Sample Buffer    2x TAE buffer (80 mM Tris/HCl, pH7.6; 
  40 mM Acetic acid; 2 mM 
  EDTA; in H2Obidest) 
      20 % Glycerol 
      8 % SDS 
      Bromphenol blue 
Running buffer    1x TAE buffer 
      0.1 % SDS 
TBS      25 mM Tris/HCl, pH 7.6 
      137 mM NaCl 
      in H2Obidest 
Thick blot filter paper   BioRAD, Hercules, USA 
0.2 µm Nitrocellulose membrane  GE Healthcare, Little Chalfont, UK 
 
SDD-AGE is a technique used for the detection of amyloidogenic proteins 
(Kryndushkin et al., 2003). Cells were harvested as described (2.3.2) and pellets 
were resuspended in an appropriate amount of lysis buffer. After 30 min 
incubation on ice, samples were centrifuged at 514 x g for 4 min at 4°C to remove 
cell debris (Eppendorf Centrifuge 5417R, Hamburg, Germany). The supernatant 
was incubated with sample buffer for 5 min at RT and subsequently loaded on an 
1.5 % agarose gel supplemented with 0.1 % SDS.  The gel was run in an 
electrophoresis chamber (Peqlab, Erlangen, Germany) at 15 V overnight at 4°C. 
On the next day, ten thick blot filter paper, eight whatman paper, a nitrocellulose 
membrane and a long whatman paper, to be used as a wick, were prepared. Four 
whatman paper, the long whatman paper and the membrane were submerged in 
TBS and the agarose gel was briefly washed with water to remove excess running 
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buffer. The blotting setup was stacked in a dry electrophoreses chamber in the 
following order: ten thick blot filter paper, four dry whatman paper, one pre-wetted 
whatman paper, the membrane, the agarose gel, three pre-wetted whatman 
paper. The wick was placed on top with both ends submerged in TBS. A weight 
was placed on top and the capillary transfer proceeded overnight at RT. The 
following day, the stack was disassembled and the membrane was further 
processed as specified for western blot analysis (2.4.7). 
2.4.7 Immunochemical detection of proteins via Western blot 
1x Blotting Buffer    25 mM Tris 
      192 mM Glycine 
      0.01 % SDS 
      20 % Methanol 
      in H2Obidest 
10x TBST     250 mM Tris/HCl, pH 7.6 
      1.37 M NaCl 
      0.05 % TWEEN-20 
      in H2Obidest 
0.2 µm Nitrocellulose membrane  GE Healthcare, Little Chalfont, UK 
0.22 µm PVDF membrane   GE Healthcare, Little Chalfont, UK 
Pierce ECL solution    Thermo Fisher Scientific, Waltham, USA 
Amersham ECL Prime Western  GE Healthcare, Little Chalfont, UK 
   Blotting Detection Reagent 
10x ReBlot Plus Strong Antibody  Merck Millipore, Billerica, USA 
   Stripping Solution 
 
Western blotting was performed to transfer proteins, separated by SDS-PAGE 
(2.4.3), onto a membrane for the detection of proteins via antibodies. In this study, 
western blotting was conducted using the wet blot method. Nitrocellulose 
membrane was used for all experiments except for the detection of 
phosphorylated eIF2α, where a PVDF membrane was used. Membrane and 
whatman paper in size of the gel were pre-equilibrated in blotting buffer. Gel, 
membrane, whatman paper and pre-wetted sponge pads were packed in 
perforated plastic plates and placed into the wet blot tank (PerfectBlue, Tank-
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Electroblotter Web, Peqlab, Erlangen, Germany). The transfer was performed at 
300 mA (small tank) or 800 mA for 65 min (large tank) at RT. Afterwards the 
membrane was blocked with 5 % milk powder in TBST for 1 h at RT and 
incubated with the primary antibody diluted in blocking buffer overnight at 4°C 
(Table 5). On the following day, the membrane was washed five times for 6 min 
with 1x TBST and incubated with the appropriate HRP-coupled secondary 
antibody diluted in blocking buffer for 1 h at RT (Table 6). The membrane was 
washed five times for 6 min with 1x TBST and incubated with ECL solution 
according to the manufacturer’s instructions. The light signal of the luminescence 
reaction was detected using the Stella imaging system (Raytest, Straubenhardt, 
Germany). For detection of additional proteins, the membrane was incubated with 
a stripping buffer (ReBlot Plus Strong Antibody Stripping Solution) for 20 min at 
RT to remove bound antibodies. The membrane was washed once with 1x TBST, 
blocked for 1 h with 5 % milk powder in TBST and stained with antibodies as 
described. 
2.4.8 Production and purification of recombinant NM protein 
Protein Purification Buffer A  10 mM Tris/HCl, pH 7.2 
      8 M Urea 
in H2Obidest 
Protein Purification Buffer B  10 mM Tris/HCl, pH 7.2 
      8 M Urea 
      1 M NaCl 
in H2Obidest 
Protein Purification Buffer C  5 mM KPhos, pH 7.2 
      8 M Urea 
in H2Obidest 
Protein Purification Buffer D  500 mM KPhos, pH 7.2 
      8 M Urea 
in H2Obidest 
 
For the production of recombinant NM, BL21 Escherichia coli (E.coli) were 
transformed with the pNOTAG-NM plasmid as described (2.5.2). A single bacteria 
colony was picked and used to inoculate 5 ml of LB medium supplemented with 
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100 µg/ml Ampicillin and grown overnight at 37°C and 180 rpm (LT-X Lab-Therm, 
Kuhner Shaker, Aachen, Germany). On the following day, the bacteria were 
transferred to 3 l of LB medium supplemented with 100 µg/ml Ampicillin and 
shaken at 180 rpm and 37°C until an OD600 of 0.6 was reached. Gene expression 
was induced by addition of 1 mM IPTG and bacteria were shaken at 180 rpm and 
30°C for 3 - 4 h. Bacteria were pelleted at 3488 x g for 15 min at RT (Heraeus 
Multifuge X3R, Thermo Fisher Scientific, Waltham, USA) and either used directly 
or stored at -80°C until further use. The bacteria pellet was resuspended in 150 ml 
of buffer A and incubated for at least 30 min at 37°C and 180 rpm. Subsequently 
the cell suspension was centrifuged at 30.000 x g for 20 min at 25°C to remove 
insoluble material. The supernatant was applied to a pre-equilibrated Q 
sepharose Fast Flow column (GE Healthcare, Little Chalfont, UK) and washed 
with 5 volumes of buffer A. The protein was eluted with a gradient of buffer A and 
B (Table 6). The eluted material was collected in 5 ml fractions and analyzed via 
SDS-PAGE and InstantBlue staining as described (2.4.3). The fractions 
containing the highest amount of NM protein were pooled and loaded on a pre-
equilibrated Macro Prep Ceramic Hydroxyapatite Type I (40 µm) (CHA) column 
(BioRAD, Hercules, USA). The column was washed with two volumes of buffer C 
and the protein was eluted with a gradient of buffer C and D (Table 7). The eluate 
was collected in fractions, which were analyzed by SDS-PAGE and InstantBlue 
staining. Fractions containing the NM protein were pooled and dialyzed twice 
against 5 l of PBS at 4°C. Protein concentration was determined and aliquots of 
100 µM (monomer concentration) were stored at -80°C. 
 
Table 6: Gradient for Q sepharose column 
Time % of buffer B 
0 min 0 
30 min 10 
90 min 70 
105 min 99 
120 min 100 
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Table 7: Gradient for CHA column 
Time % of buffer D 
0 min 0 
30 min 10 
90 min 50 
105 min 99 
120 min 100 
 
2.5 Molecular biological methods 
2.5.1 Generation of chemically competent E.coli 
LB Medium     2 % LB Broth-agar 
in H2Obidest 
 
A liquid culture of 2 ml LB medium was inoculated with BL21 E.coli and incubated 
in a shaker at 220 rpm overnight at 37°C (LT-X Lab-Therm, Kuhner Shaker, 
Aachen, Germany). On the following day, 100 ml of LB medium were inoculated 
with 500 µl of the overnight culture. Bacteria were shaken at 220 rpm and 37°C 
until an OD600 of 0.3 was reached. All following steps were performed on ice. The 
bacteria were cooled for 10 min and subsequently centrifuged at 1500 x g for 10 
min at 4°C (Heraeus Multifuge X3R, Thermo Fisher Scientific, Waltham, USA). 
The supernatant was discarded and the bacteria were resuspended in 10 ml 0.1 
M MgCl2. The bacteria were centrifuged at 1500 x g for 10 min at 4°C and the 
pellet was resuspended in 20 ml 0.1 M CaCl2. After an incubation of 20 min, 
bacteria were centrifuged as before and the pellet was resuspended in 1 ml 0.1 M 
CaCl2 supplemented with 15 % glycerol. Aliquots of 50 µl were snap frozen and 
stored at -80°C. 
2.5.2 Transformation of chemically competent E.coli 
pNOTAG-NM    Provided by Jens Tyedmers 
 
BL21 E.coli were thawed on ice and 10 - 100 ng of DNA was added. After an 
incubation of 30 min on ice, bacteria were subjected to a heat shock at 42°C for 
42 sec and subsequently cooled on ice. 500 µl of LB medium was added and the 
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bacteria were incubated at 300 rpm for 30 - 90 min at 37°C (Thermomixer 
Compact, Eppendorf, Hamburg, Germany). Bacteria were spun down at 514 x g 
for 3 min at RT (Eppendorf Centrifuge 5417R, Hamburg, Germany) and most of 
the supernatant was discarded. Bacteria were resuspended in the residual 
medium and plated onto LB agar plates supplemented with 100 µg/ml Ampicillin. 
Plates were incubated overnight at 37°C and afterwards stored at 4°C. 
2.6 Image data analysis and statistics 
2.6.1 Image editing 
Confocal images captured with the LSM 700, the widefield fluorescent microscope 
or the LSM 710 (Zeiss, Jena, Germany) were processed using Zen 2010 (black 
edition) or Zen 2012 (blue edition) software (Zeiss, Jena, Germany). Images 
captured with the LSM 800 Ariyscan were subjected to deconvolution to obtain 
superresolution images using the Zen 2012 (blue edition) software. 
2.6.2 Image data analysis using Cell Profiler 
Images obtained using the Cell Voyager 6000 (Yokogawa, Tokyo, Japan) were 
analyzed with Cell Profiler 2.1 image analysis software (Carpenter et al., 2006). 
Image analysis routines were developed for identification of stress granules and 
NM aggregates. In brief, nuclei and cytoplasm were identified based on 
morphology and intensity of Hoechst and CellMask staining. Stress granules were 
detected by intensity of the respective staining and size. Cells were classified as 
stress granule positive when three or more stress granules were identified in the 
cytoplasm. To identify NM aggregates, the Ilastik segmentation tool was used for 
pixel classification. The number of NM expressing cells as well as aggregate 
bearing cells was determined by using the pixel classifier and intensity levels of 
NM. 
2.6.3 Image data analysis of time-lapse experiments 
Images obtained from time-lapse experiments were subjected to an in-house 
deep learning approach to detect nuclei and cytoplasm. This approach is based 
on the software U-Net architecture for convolutional neural networks and Theano 
(performed by Manuel Schölling (IDAF, DZNE)). Using Cell Profiler an image 
analysis routine was developed to measure the fluorescence intensities for each 
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cell over time. The pixel classifier generated by the deep learning approach was 
used to detect nuclei and cytoplasm. The standard deviation of the fluorescence 
signal of the SG marker protein (G3BP1-mCherry) was taken as a measure of SG 
assembly or disassembly. The fluorescence signal of the SG marker protein is 
evenly distributed in the cytoplasm with a low standard deviation when no SGs 
are present. Upon SG formation the standard deviation becomes larger, or 
smaller upon SG disassembly and therefore the change in standard deviation was 
taken as a measure. 
2.6.4 Statistical analysis 
For statistically analyzed data, at least three biological replicates were analyzed. 
Statistical analysis was performed using Graph Pad Prism 6 (Graph Pad 
Software, La Jolla, USA) and data was analyzed using the unpaired two-tailed 
Student´s t-test for single comparisons or one-way ANOVA with Dunnett’s 
multiple comparisons test. Statistical analysis of time-lapse experiments and high-
throughput image analysis was performed by Manuel Schölling (IDAF, DZNE). 
For analysis of time-lapse data, a mixed linear model was used to analyze the 
slopes of the measured standard deviation of the fluorescence over time. 
Increase of local fluorescence was analyzed using a generalized linear model with 
corrections for experiment-dependent effects. All other analysis of high-
throughput data was performed using a logistic regression model to analyze 
whether the ratio of positive to negative cells is significantly different with 
corrections for experiment-dependent effects. A p-value less than 0.05 was 
considered as statistically significant (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 
0.0001). 
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3. Results 
Several proteins that form insoluble inclusions in neurodegenerative diseases 
have been shown to sequester proteins that are part of ribonucleoprotein (RNP) 
granules, comprising mainly RBPs (Gunawardana et al., 2015; Lee et al., 2016). 
RBPs itself have been implicated in a range of neurodegenerative diseases (Li et 
al., 2013; Ramaswami et al., 2013). A hallmark of many RBPs is the presence of 
low complexity domains, which are often similar to yeast prion domains and are 
also referred to as prion-like domains (PrLDs). Under physiological conditions, 
PrLDs drive transient phase separation such as assembly of stress granules. The 
fact that PrLD-containing proteins are involved in RNP formation and aberrant 
protein inclusions argues that the two processes might be somehow interrelated. 
To identify putative PrLDs, algorithms were designed based on the characteristics 
of prion domains found in yeast proteins, such as Sup35 of Saccharomyces 
cerevisiae (Alberti et al., 2009). Sup35 has been extensively studied and its prion 
domain (PrD) has been shown to propagate as a prion in mammalian cells 
(Hofmann et al., 2013; Krammer et al., 2009). Using the PrD of Sup35 (NM) as a 
model of cytosolic prion aggregation, a previous study from our lab examined the 
interaction partners of soluble and aggregated NM. When HA-tagged NM is 
expressed in N2a neuroblastoma cells it remains soluble (Fig. 8A), but 
aggregation can be induced by exposure to recombinant NM fibrils. Single cell 
clones that propagate morphologically distinct NM prions have been previously 
isolated and characterized (Krammer et al., 2009) (Fig. 8A). To identify interaction 
partners of morphologically diverse NM prions, LC-MS/MS analysis of soluble and 
aggregated NM-HA had previously been performed by a former coworker (Verena 
Arndt), using N2a wildtype cells, N2a cells expressing soluble NM-HA (N2a NM-
HAsol) and N2a cell clones carrying NM-HA prion aggregates (N2a NM-HAagg) 
(Fig. 8B, C). As all three NM-HAagg clones exhibited comparable interactor lists, 
interactomes were pooled for analysis. Gene Ontology analysis revealed that the 
NM-HAsol and NM-HAagg interactomes were highly enriched for proteins involved 
in RNA metabolism (Fig. 8D), similar to the proteome of SGs (Jain et al., 2016). 
Examining the physicochemical features of the NM-HA interactomes, using the 
cleverMachine algorithm, revealed that compared to a random sample of the 
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mouse proteome, the interactomes of soluble and aggregated NM-HA were 
enriched in intrinsic disorder and nucleic acid binding ability (Fig. 8E, F) (Klus et 
al., 2014). Both features were also enriched in the proteome of SGs (Fig. 8G).  
 
 
 
Figure 8. The NM interactome is enriched for proteins with intrinsic disorder. (A) 
Immunofluorescence staining of N2a cells stably expressing soluble yeast NM-HA and 
N2a subclones 1c, 2e and 3b persistently producing NM-HA prion aggregates. NM was 
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detected using mAb anti-HA (green) and nuclei were stained with Hoechst (blue). Scale 
bar: 5 µm (Images: Verena Arndt) (B) Biological triplicates of N2a wildtype cells, N2a cells 
expressing soluble NM-HA (N2a NM-HAsol) and N2a cells stably carrying NM-HA prion 
aggregates (N2a subclones 1c, 2e and 3b combined as N2a NM-HAagg) were subjected 
to LC-MS/MS analysis (performed by Verena Arndt). (C) Number of proteins found as 
interactors of soluble and aggregated NM-HA from cell clones 1c, 2e and 3b combined. 
(D) Gene Ontology enrichment analysis of NM-HAsol and NM-HAagg interactomes. Shown 
are the top five Gene Ontology biological process annotations. Benjamini p-value is 
shown. (E) Box-plots show intrinsic protein disorder of interactors calculated using 
DisProt (Cox et al., 2014). Intrinsic disorder of interactors was compared to that of a 
random subset of the mouse proteome. P-values are 1.7 x 10-8 and 3.48 x 10-9, 
respectively. Statistics were performed using the Kolmogorov-Smirnov test. (F) Box-plots 
display the nucleic acid binding ability of interactors calculated using the scale of 
nonClassical RBD compared to that of a random subset of the mouse proteome (Castello 
et al., 2012). P-values are 3.30 x 10-13 and 3.46 x 10-11, respectively (Kolmogorov-
Smirnov test). (G) Box-plots show intrinsic protein disorder (upper panel) calculated using 
DisProt (Cox et al., 2014) and nucleic acid binding ability (lower panel) calculated using 
the Castello scale (Castello et al., 2012) for SG components compared to a random 
subset of the human proteome (Intrinsic disorder and nucleic acid binding ability analysis 
were performed by Benedetta Bolognesi). 
 
The interactomes of soluble and aggregated NM-HA appear very similar, although 
twice as many proteins were found to bind to aggregated NM as compared to 
soluble NM. Mass spectrometry analysis revealed that aggregated NM also 
interacted with proteins of the degradation machinery. Interaction of key hits with 
NM prions was validated by immunofluorescence staining (Fig. 9). Mammalian 
cells degrade misfolded proteins via autophagy, which is a non-selective 
degradation system for cytoplasmic constituents. Valosin-containing protein 
(VCP) and p62 play roles in the clearance of ubiquitinated proteins via autophagy 
and were both identified as putative NM prion interactors. Immunofluorescence 
staining of NM-HAagg cells confirmed a colocalization of VCP and p62 with NM 
prions (Fig. 9). The interactome of aggregated NM further identified Ubiquilin-2, 
which is a regulator of protein degradation via the proteasome and autophagy, 
and Keap1, which is involved in the proteasome degradation pathway. 
Colocalization of Ubiquilin-2 and Keap1 with NM prions demonstrated that both 
proteins are associated with NM prion aggregates (Fig. 9). These results suggest 
that cells respond to NM prions by subjecting them to degradation by autophagy. 
Due to the striking similarities of the NM-HA interactomes and the SG proteome 
we further investigated the relationship between SGs and NM prion aggregates. 
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In this study we used the PrD of Sup35 to assess similarities and differences of 
SGs and cytosolic prion aggregates and analyzed whether these two assemblies 
influence each other. 
 
 
 
Figure 9. NM prions recruit proteins of the degradation machinery. 
Immunofluorescence staining of N2a NM-HAagg cells was performed using mAb anti-HA 
(red) and mAb anti-p62 or mAb anti-FLAG (green). Nuclei were visualized using Hoechst 
(blue). Scale bar: 5 µm. 
 
3.1 NM acts as a cytosolic prion in HeLa cells 
In previous studies, N2a cells were used to express and investigate NM. As N2a 
cells do not mount a good SG response, a different cell line was chosen for the 
examination of SGs together with NM. HeLa cells are often used as a model to 
study SGs in different experimental setups, hence this cell line was chosen for 
further investigations (Kedersha et al., 2005; Kroschwald et al., 2015). To verify 
that NM could act as a prion in HeLa cells, stable HeLa cell lines expressing HA-
tagged and GFP-tagged NM were generated by lentiviral transduction. When 
expressed in HeLa cells, NM remained in a soluble state, but readily aggregated 
upon exposure to recombinant NM fibrils (Fig. 10B). Phenotypically distinct 
aggregate types were detectable after exposure to NM fibrils, which might 
represent NM-HA variants as seen previously in N2a cells (Krammer et al., 2009). 
A sedimentation assay confirmed that NM was enriched in the insoluble fraction 
when exposed to NM fibrils, but was otherwise detected in the soluble fraction 
(Fig. 10C). 
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Figure 10. NM replicates as a prion in HeLa cells. (A) Schematic diagram of the 
experiments. (B) Confocal microscopy analysis of cellular distribution of soluble (HeLa 
NM-HAsol) or aggregated (HeLa NM-HAagg) NM-HA in HeLa cells. HeLa cells expressing 
soluble HA-tagged NM were exposed to 5 µM recombinant fibrillar NM (monomer 
concentration) to induce aggregation. NM-HA was detected using mAb anti-HA (green). 
Nuclei were stained with Hoechst (blue). Scale bar: 10 µm. (C) A sedimentation assay 
was performed with HeLa cells harboring either soluble or aggregated NM-HA. NM-HA 
was detected using mAb anti-HA. 10x more of the pellet fraction was loaded. S: 
Supernatant, P: Pellet. (D) Cell lysates of HeLa, HeLa NM-HAsol and HeLa NM-HAagg 
cells were separated by semi-denaturing detergent - agarose gel electrophoresis (SDD-
AGE). NM-HA was detected using mAb anti-HA. (E) HeLa cells expressing soluble NM-
GFP were exposed to 5 µm recombinant fibrillar NM (monomer concentration) for 48 h 
and subsequently subjected to live cell imaging for 16 h. Arrows mark cells undergoing 
cell division and transmitting induced aggregates to their progeny. Scale bar: 20 µm. (F) 
Donor HeLa cells expressing soluble NM-HA or HeLa NM-HAagg cells were cocultured 
with recipient HeLa cells expressing soluble NM-GFP for 48 h. Cells were stained for NM-
HA using mAb anti-HA (red) and nuclei were stained with Hoechst (blue). Scale bar: 10 
µm. 
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The amyloid nature of the NM-HA aggregates was shown by performing a semi-
denaturing detergent – agarose gel electrophoresis (SDD-AGE) (Kryndushkin et 
al., 2003) (Fig. 10D). Wildtype HeLa cells, HeLa cells expressing soluble NM-HA 
(HeLa NM-HAsol) and HeLa cells persistently propagating NM-HA aggregates 
(HeLa NM-HAagg) were analyzed. For HeLa NM-HAsol cells, only one band could 
be detected, representing the monomeric protein. HeLa NM-HAagg cells on the 
other hand showed a large SDS resistant smear, representing the aggregated, 
amyloidogenic NM-HA. One important feature of prions is the propagation of the 
prion phenotype to daughter cells. To assess the mitotic stability of NM 
aggregates, HeLa NM-GFP cells were incubated with recombinant NM fibrils to 
induce aggregation and were subsequently subjected to live cell imaging (Fig. 
10E). Induced NM-GFP aggregates were evenly distributed to both daughter cells 
during cell division, showing that NM aggregates can be propagated to their 
progeny in HeLa cells. Furthermore, prion replication depends on the formation of 
infectious particles, which are able to infect neighboring cells and induce a self-
perpetuating prion state. By coculturing HeLa NM-HAagg cells together with HeLa 
NM-GFPsol cells the infectivity to bystander cells was tested (Fig. 10F). NM-HA 
aggregates successfully induced the aggregation of NM-GFP in neighboring cells, 
whilst soluble NM-HA was unable to. Taken together, these results show that NM 
acts as a prion when expressed in HeLa cells. 
 
3.2 Stress granules and NM prions share similar marker proteins 
The interactome study of NM prions identified several RBPs that are also part of 
the proteome of SGs. Among the identified proteins, G3BP and TIA-1 are known 
marker proteins for SGs. Both proteins are RBPs that play crucial roles in the 
assembly of SGs (Gilks et al., 2004; Tourriere et al., 2003). To validate the 
interactome findings, we tested for the colocalization of NM prions and G3BP and 
TIA-1 (Fig. 11). Immunofluorescence staining of HeLa NM-HAagg cells showed the 
sequestration of TIA-1 and G3BP by NM prions (Fig. 11A). For NM-HA almost no 
signal was detectable outside of the prion aggregate, whereas G3BP and TIA-1 
showed only a weak sequestration by the prion with most of the protein still being 
located in the cytoplasm and/or nucleus. To further validate the interaction, 
immunoprecipitation of endogenous G3BP and TIA-1 was performed in HeLa NM-
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HAsol and HeLa NM-HAagg cells. In the pull-down experiment, NM-HA was only 
detected in prion bearing cells (Fig. 11B). Hence, the interaction of the SG marker 
proteins seems to be prion specific. These results led us to the suggestion that 
NM-HA might also be recruited into SGs.  
 
 
 
Figure 11. Stress granule marker colocalize with NM prions. (A) HeLa cells 
expressing soluble NM-HA were exposed to 5 µm recombinant fibrillar NM (monomer 
concentration) for 48 h and cells were subsequently fixed. Immunofluorescence staining 
was performed using mAb anti-HA (green) and pAb anti-TIA-1 or mAb anti-G3BP (red). 
Nuclei were stained with Hoechst (blue). Scale bar: 10 µm. (B) G3BP and TIA-1 were 
immunoprecipitated (IP) from cell lysates of HeLa NM-HAsol or HeLa NM-HAagg cells. 
Immune complexes were separated by SDS-PAGE and examined by western blot for the 
presence of G3BP or TIA-1 and NM-HA. 
 
To test our hypotheses, we treated HeLa cells expressing soluble NM-HA with the 
SG inducing drug sodium arsenite, which triggers oxidative stress in cells. 
Treatment with sodium arsenite resulted in a robust induction of SGs, well-defined 
cytoplasmic foci (Fig. 12). Immunofluorescence staining using G3BP and TIA-1 as 
SG markers revealed that soluble NM-HA was indeed sequestered into SGs. 
Upon arsenite treatment, G3BP and TIA-1 accumulated in SGs with only a faint 
staining in the residual cytoplasm and nucleus. In contrast to the strong 
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recruitment of G3BP and TIA-1 to SGs, NM-HA was recruited to SGs, but still 
exhibited a strong signal in the remaining cytosol. 
 
SGs can be induced by a variety of treatments leading to SGs with distinct 
compositions (Aulas et al., 2017). To test whether NM-HA is also part of SGs 
when induced by different stresses, we treated HeLa NM-HAsol cells with a range 
of known SG inducers. 
 
 
Figure 12. Soluble NM localizes to stress granules. HeLa cells expressing soluble 
NM-HA were exposed to 0.5 mM sodium arsenite for 1 h and cells were subsequently 
fixed. Immunofluorescence staining was performed using mAb anti-HA (green), mAb anti-
G3BP (red) and pAb anti-TIA-1 (white). Nuclei were stained with Hoechst (blue). Scale 
bar: 10 µm. 
 
We tested five different SG inducing stimuli and performed an 
immunofluorescence staining to assess colocalization of NM-HA and the SG 
marker TIAR (Fig. 13). MG132 inhibits the proteasome, leading to the appearance 
of SGs for a few hours during treatment (Mazroui et al., 2007), whilst the 
treatment with dsRNA mimics a viral infection, thereby inducing SGs as part of the 
immune response (Scadden, 2007; Zhang et al., 2014). Both stresses induce SGs 
by phosphorylation of eIF2α, as it is also the case for heat shock treatment 
(Clemens, 2001). In contrast, SG assembly induced by treatment with sodium 
chloride (NaCl) is independent of eIF2α phosphorylation and SG assembly is 
regulated by macromolecular crowding (Bevilacqua et al., 2010; Bounedjah et al., 
2012). Note that SGs induced by NaCl have a distinct appearance compared to 
SGs induced by the other stresses, but are considered bona fide SGs (Kedersha 
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et al., 2016). Nevertheless, all of the different stresses induced SGs that 
sequestered soluble NM-HA (Fig. 13). NM-HA being part of different subtypes of 
SGs made it a good model to further study the relationship between SGs and 
cytosolic prion aggregates.  
 
 
 
Figure 13. NM containing stress granules can be induced by diverse stimuli. HeLa 
cells expressing soluble NM-HA were exposed to (a) 100 µM MG132 for 2 h, (b) 200 mM 
NaCl for 1 h, (c) heat shock at 45°C for 30 min or were transfected with either (d) 300 ng 
HMW dsRNA or (e) 300 ng LMW dsRNA. Cells were subsequently fixed and 
immunofluorescence staining was performed using mAb anti-HA (green) and mAb anti-
TIAR (red). Nuclei were stained with Hoechst (blue). Arrows mark SGs containing NM. 
Scale bar: 10 µm. 
 
Next we asked which part of NM is important for the sequestration of NM into 
SGs. A previous study of our lab defined which regions within NM are important in 
mammalian cells for the three sequential steps of prion replication: de novo 
induction of prions, fragmentation of NM prions and transmission of infectious 
particles to daughter cells (Duernberger et al., 2018). Surprisingly, all three steps 
were facilitated by one region within NM: the last three repeats of the OPR and 
the CTN. To investigate which subdomain of NM is important for the localization 
to SGs, we made use of the NM deletion mutants that were generated in the 
previous study (Fig. 14A) (Duernberger et al., 2018). We transduced HeLa cells 
with six different NM mutants, carboxyterminally tagged with HA: NM ∆ 1-39, 
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lacking the QNR; NM ∆ 39-57, lacking OPR repeat 1 and partially repeat 2; NM ∆ 
39-74, with a deletion of OPR repeats 1 – 3; NM ∆ 75-97, lacking OPR repeats 4 
– 6; NM ∆ 75-123, with a deletion of OPR repeats 4 – 6 and the CTN, and NM ∆ 
98-123 lacking the CTN (Fig 14A). HeLa cells expressing full-length NM or mutant 
NM were treated with 500 µM sodium arsenite for 1 h to induce SGs and an 
automated immunofluorescence analysis was performed (Fig. 14B-D). In all cell 
lines SGs could be induced, as shown by staining with the SG marker TIAR (Fig. 
14C). However, the level of NM-HA being sequestered into SGs varied upon the 
different mutants. To analyze for each cell line how much NM-HA was located in 
SGs, an image analysis was performed (Fig. 14D). As NM-HA is evenly 
distributed in the cytoplasm with a locally increased signal in SGs, we measured 
the increase of fluorescence in SGs compared to the cytoplasm. Full-length NM 
showed the strongest recruitment to SGs, whereas NM mutants lacking the CTN 
(NM ∆ 75-123) or the first three repeats of the OPR (NM ∆ 39-74) were the least 
sequestered into SGs. Interestingly, NM with a deletion of repeat 4 – 6 of the OPR 
(NM ∆ 75-97) showed a better recruitment to SGs than when additionally the CTN 
was lacking (NM ∆ 75-123). This indicated that the size of the deletion seemed to 
be important for the binding of NM to SGs. Furthermore, NM lacking repeat 1 – 3 
of the OPR (NM ∆ 39-74) was less sequestered into SGs than NM lacking only 
repeat 1 and partially repeat 2 (NM ∆ 39-57), emphasizing that larger regions are 
needed for recruitment to SGs. Deletion of the QNR (NM ∆ 1-39) had only a slight 
effect on the recruitment of NM-HA to SGs. This demonstrates that the last part of 
the N domain, comprising the CTN and the OPR, plays an important role in the 
recruitment of NM to SGs. However, binding of NM to SGs seems to be facilitated 
by rather large regions as smaller deletions had a minor effect on recruitment 
compared to larger deletions. This leads to the suggestion that interaction of NM 
with SGs requires rather multiple interactions then one defined subdomain. 
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Figure 14. The OPR and the CTN are most important for recruitment to SGs. (A) 
Scheme of full-length NM and the six deletion mutant constructs used in this study. QNR: 
aa 1-39, OPR: aa 41-97, CTN: aa 98-123. NM ∆ 1-39, with a deletion of the QNR; NM ∆ 
39-57, with a deletion of repeat 1 and part of repeat 2; NM ∆ 39-74, with a deletion of 
repeat 1 – 3; NM ∆ 75-97, with a deletion of repeats 4 – 6; NM ∆ 75-123, with a deletion 
of repeats 4 – 6 and the CTN and NM ∆ 98-123 with a deletion of the CTN. Numbers 
refer to amino acids. (B) Schematic diagram of the experiment. HeLa NM-HAsol cells were 
treated with 0.5 mM sodium arsenite for 1 h and subsequently fixed. Images for analysis 
were taken using the automatic confocal microscope Cell Voyager 6000 (C) 
Immunofluorescence staining was performed using mAb anti-HA (red) and mAb anti-
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TIAR (green). Nuclei were stained with Hoechst (blue). Scale bar: 10 µm (D) Analysis of 
sequestration of NM-HA mutants into SGs. Shown is the increase of fluorescence 
compared to the fluorescence signal of the cytoplasm. Bars represent mean values ± 
SEM (n=3). The experiment was performed three times in triplicates. At least 1500 cells 
were analyzed. Statistical analysis was performed using a generalized linear model (****p 
≤ 0.0001). 
 
3.3 NM prions and SGs are distinct assemblies 
In the previous experiments we could show that SG marker proteins colocalize 
with NM prions and that soluble NM is a part of SGs. Hence, there are some 
similarities in the interactome of these two assemblies. To further analyze the 
shared interactome of SGs and NM prions, we checked for the recruitment of 
RNA to NM prions. RNA is one of the most crucial components of SGs, as the 
main function of SGs is to sequester mRNAs for translational repression 
(Kedersha et al., 1999).  
 
 
 
Figure 15. NM prions show colocalization with RNA but not with P body marker 
Dcp1a. (A) HeLa cells were treated with 0.5 mM sodium arsenite for 1 h to induce SGs 
and HeLa NM-HAagg cells were left untreated. RNA was stained using SYTO RNASelect 
(green) and cells were subsequently fixed. Immunofluorescence staining was performed 
using mAb anti-TIAR or mAb anti-HA (red). Nuclei were stained with Hoechst (blue). 
Scale bar: 10 µm. (B) Immunofluorescence staining of HeLa NM-HAsol and HeLa NM-
HAagg cells was performed using mAb anti-HA (green) and mAb anti-Dcp1a (red). Nuclei 
were stained with Hoechst (blue). High magnification views of the indicated regions are 
shown in the lower panel. Scale bar: 10 µm. 
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We stained for total RNA using a nucleic acid dye that exhibits bright green 
fluorescence upon binding to RNA (SYTO RNASelect). Immunofluorescence 
staining of HeLa cells treated with sodium arsenite to induce SGs showed a 
strong signal for RNA in the nucleus and a weak signal in the cytoplasm (Fig. 
15A). Co-staining with the SG marker TIAR showed a colocalization of RNA and 
SGs. In HeLa NM-HAagg cells, RNA was detectable in NM prions (Fig. 15A). 
Hence, both assemblies share RNA as a component. Translationally repressed 
mRNAs do not only accumulate in SGs, but also in other cytoplasmic foci, as for 
example in P bodies. P bodies contain the mRNA decay machinery and are 
present in unstressed cells, but can be further induced in response to stress 
(Kedersha and Anderson, 2007). SGs and P bodies are closely related RNP 
granules that share some components. Furthermore, SGs and P bodies physically 
interact during stress and mRNAs can cycle between them (Kedersha et al., 
2005). Therefore, we wondered whether NM prions and P bodies share 
components. Immunofluorescence staining of the P body marker Dcp1a in 
unstressed HeLa NM-HAsol cells showed no colocalization of soluble NM-HA in P 
bodies (Fig. 15B). Moreover, there was no recruitment of Dcp1a to NM prions as 
seen by an immunofluorescence staining of HeLa NM-HAagg cells (Fig. 15B). 
Although SGs and P bodies are both RNP granules, NM shows no interaction with 
P bodies. Hence, the similarities between SGs and NM prions are specific. 
 
The phosphorylation of eIF2α is an important step in SG assembly. Upon most 
SG inducing treatments, eIF2α gets phosphorylated at serine 51 and leads to a 
translational arrest by preventing the assembly of the 43S preinitiation complex 
(Kedersha et al., 1999). To analyze whether induction of NM aggregation by 
exogenous fibrils has an effect on the phosphorylation of eIF2α, wildtype HeLa 
cells or HeLa cells expressing soluble NM-HA were treated either with arsenite or 
recombinant NM fibrils and harvested at different time points for western blot 
analysis (Fig. 16). 
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Figure 16. NM fibrils do not trigger phosphorylation of eIF2α. (A) HeLa cells with or 
without soluble NM-HA were exposed to 0.5 mM sodium arsenite for 30 min, 60 min or 
left untreated. Western blotting was performed using pAb anti-eIF2α, pAb anti-phospho-
eIF2α and mAb anti-HA. Actin served as loading control. (B) HeLa cells with or without 
soluble NM-HA were exposed to 5 µM recombinant fibrillar NM, harvested after the 
indicated time points and subjected to western blotting. HeLa cells carrying stable NM 
prion aggregates (HeLa NM-HAagg) were loaded as control and HeLa cells treated with 
0.5 mM sodium arsenite (ARS) for 60 min served as positive control. Western blotting 
was performed using pAb anti-eIF2α, pAb anti-phospho-eIF2α and mAb anti-HA. Actin 
served as loading control. 
 
The treatment of HeLa and HeLa NM-HAsol cells with sodium arsenite led to the 
phosphorylation of eIF2α, as expected (Fig. 16A). Thus, the presence of soluble 
NM-HA has no effect on the phosphorylation. In contrast, incubation of HeLa cells 
with recombinant NM fibrils did not lead to any phosphorylation of eIF2α (Fig. 
16B). Additionally, HeLa cells carrying stable NM prions showed no 
phosphorylation of eIF2α. We conclude that NM prions and SGs do not share the 
same pathway of activation. 
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SGs are highly dynamic structures, which assemble within minutes after exposure 
to stress. Fluorescence recovery after photobleaching (FRAP) studies have 
shown that different SG components, including G3BP and TIA-1, have a rapid 
turnover in SGs (Kedersha et al., 2000; Kedersha et al., 2005). Moreover, it has 
been suggested that stress granules have liquid-like properties (Kroschwald et al., 
2015). To compare the dynamics of SGs to our NM prions we used FRAP 
analysis (Fig. 17).  
 
 
 
Figure 17. NM prions are not dynamic as stress granules (A-B) HeLa cells expressing 
either G3BP1-mCherry (A) or NM-GFP (B) were used for FRAP analysis. NM-GFP 
expressing cells were exposed to 5 µM recombinant fibrillar NM (monomer concentration) 
for 48 h and G3BP1-mCherry expressing cells were exposed to 0.5 mM sodium arsenite 
30 min prior to photobleaching. High magnification views of the indicated regions are 
shown before, immediately after and 1 min (A) or 4 min (B) after photobleaching. Circles 
represent bleached areas. Scale bar: 10 µm. (C-D) Plots show the normalized 
fluorescence intensity of bleached stress granules (C) and bleached NM-GFP prions (D). 
(G3BP1-mCherry n=14; NM-GFP n=14). 
 
 Results 
 
 
 
58 
We used HeLa cells expressing fluorescently tagged G3BP1 from bacterial 
artificial chromosomes (BAC) to detect SGs while performing live cell imaging 
(Mateju et al., 2017; Poser et al., 2008). Cells were treated with 0.5 mM arsenite 
to induce SGs and were subjected to FRAP analysis 30 min later. As expected, 
G3BP sowed a rapid and almost complete recovery with a half time of ~10 sec 
(Fig. 17A, C). To detect NM prions in living cells, we used HeLa cells expressing 
NM-GFP. Cells were exposed to recombinant NM fibrils 48 h prior to imaging to 
induce aggregation. After bleaching part of the NM prion, imaging was continued 
for 4 min without any recovery being measured (Fig. 17B, D). Prolonged imaging 
was difficult as cells got photodamaged and/or moved. Hence, in contrast to SGs, 
NM prions are not dynamic assemblies. In conclusion, the data demonstrates that 
SGs and NM prions share several components, but apart from that are different 
assemblies regarding their induction and dynamics. 
 
3.4 NM has only a minor effect on SG dynamics 
So far we analyzed similarities and differences of SGs and NM prions. Both 
assemblies share several components but show different dynamics. This led us to 
question whether NM prions might influence SG dynamics. First we tested 
whether SGs can still assemble in the presence of NM prions. HeLa NM-HAsol 
cells were incubated with NM fibrils for 48 h to induce aggregation and were 
afterwards incubated with arsenite to induce SGs (Fig. 18A, B). Using the SG 
marker TIAR, SGs could be detected in cells harboring NM prions (Fig. 18B). 
Furthermore, TIAR could be detected colocalizing with the NM prions, indicating 
that SGs cannot only form in the presence of NM prions but also that 
sequestration of SG components into NM prion aggregates has no effect on the 
induction of SGs. To assess if the presence of SGs has an effect on the induction 
of NM prions, HeLa NM-HAsol cells were first treated with a low dose of arsenite to 
induce SGs and then NM fibrils were added to induce aggregation of NM (Fig. 
18C, D). As treating cells with arsenite for a long period of time is toxic to the 
cells, a medium exchange was performed after six hours. 24 h post fibril 
induction, cells were stained and imaging revealed that cells were able to 
assemble NM prions even in the presence of SGs (Fig. 18D). 
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Figure 18. Stress granules and NM prions can form in the presence of each other. 
(A) Schematic diagram of the experiment. (B) HeLa NM-HAsol cells were exposed to 5 µM 
recombinant fibrillar NM (monomer concentration) for 48 h before 0.5 mM sodium 
arsenite was added for 1 h. Cells were subsequently fixed and subjected to 
immunofluorescence staining. NM was stained using mAb anti-HA (green) and SGs were 
stained using mAb anti-TIAR (red). Nuclei were stained with Hoechst (blue). Scale bar: 
10 µm. (C) Schematic diagram of the experiment. M.ex.: medium exchange (D) HeLa 
NM-HAsol cells were exposed to 100 µM sodium arsenite and after 30 min 5 µM 
recombinant fibrillar NM (monomer concentration) was added. The medium was 
exchanged after 6 h and cells were further cultivated for 18 h. Afterwards cells were fixed 
and immunofluorescence staining was performed using mAb anti-HA (green) and mAb 
anti-TIAR (red). Nuclei were stained with Hoechst (blue). Scale bar: 10 µm. 
 
Surprisingly, no TIAR was sequestered into the newly formed NM prion 
aggregates. SGs could still be detected in many cells, although arsenite was 
removed 18 h before fixation. As under normal conditions SGs disassemble within 
a few hours after the stress has been released, SG disassembly seems to be 
impaired during induction of NM prion aggregates. We conclude that SGs and NM 
prions can form in the presence of each other. 
 
To investigate the effect of soluble and aggregated NM on SG dynamics, 
assembly and disassembly, we conducted live cell imaging of these events. We 
used HeLa cells expressing the G3BP1-mCherry BAC construct and transduced 
them with a construct encoding for NM-GFP. To induce aggregation of NM-GFP, 
cells were incubated with recombinant NM fibrils 48 h prior to the experiment. 
First, the effect of NM on SG dynamics was analyzed by performing FRAP 
analysis on SGs. HeLa G3BP1-mCherry, HeLa G3BP1-mCherry NM-GFPsol and 
HeLa G3BP1-mCherry NM-GFPagg cells were treated with 0.5 mM arsenite 30 min 
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prior to bleaching and cells were subsequently subjected to FRAP analysis (Fig. 
19A, B). As seen before, in HeLa cells expressing only G3BP1-mCherry, G3BP 
showed a rapid and almost complete recovery (Fig. 19B). Surprisingly, G3BP 
showed the same rapid recovery in HeLa cells expressing either soluble or 
aggregated NM-GFP (Fig. 19B). There was no difference in recovery rate or ratio 
of mobile and immobile fraction detectable. This led us to the conclusion that 
neither aggregated nor soluble NM has an effect on SG dynamics. Next, we 
wanted to assess whether there is an effect of NM on the assembly of SGs. 
Arsenite was added to cells and imaging was started directly afterwards for 60 
min (Fig. 19A, C). For analysis of images, the standard deviation of G3BP1-
mCherry fluorescence was measured for each cell over time as a measure of SG 
assembly. Before SGs assembled, the fluorescence signal was evenly distributed 
throughout the cytoplasm with a relatively small standard deviation. Upon stress 
treatment, G3BP accumulated in cytoplasmic foci, thereby increasing the 
standard deviation of the fluorescence signal. Analyzing the slopes of the 
increase in standard deviation of the fluorescence signal showed that SG 
assembly is slightly impaired in HeLa cells carrying NM-GFP prions (Fig. 19D). 
Assembly rates were slower when NM prions were present, but after 60 min 
incubation with arsenite, all cell lines showed a similar SG pattern. For analysis of 
SG disassembly, cells were incubated with arsenite for 1 h, followed by a medium 
exchange and subsequent imaging for 3 h (Fig. 19A, E). Imaging was started 15 
min after the medium was exchanged, as imaging positions needed to be verified. 
Analysis was performed in the same way as for SG assembly. The slopes of SG 
disassembly showed that for the first 2 h there was no difference between the 
different cell lines (Fig. 19F). During the last hour of imaging, SGs in HeLa 
G3BP1-mCherry cells almost completely dissolved, however in HeLa cells 
expressing soluble or aggregated NM-GFP some SGs seemed to be more 
persistent. In conclusion, these findings show that SGs can form in the presence 
NM prions, but show a slight impairment in assembly und disassembly.  
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Figure 19. NM does not influence stress granule dynamics. (A) Schematic diagram of 
the experiment. (B) HeLa G3BP1-mCherry, G3BP1-mCherry NM-GFPsol and G3BP1-
mCherry NM-GFPagg cells were used for FRAP analysis. Cells were exposed to 0.5 mM 
sodium arsenite to induce stress granules, 30 min prior to photobleaching. (G3BP1-
mCherry n=39; G3BP1-mCherry NM-GFPsol n=44; G3BP1-mCherry NM-GFPagg n=36) (C-
D) HeLa G3BP1-mCherry, G3BP1-mCherry NM-GFPsol and G3BP1-mCherry NM-GFPagg 
were subjected to live cell imaging to monitor SG assembly. Cells were treated with 0.5 
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mM sodium arsenite and imaged for 60 min. (C) Images taken directly (1 min) and 60 min 
after addition of sodium arsenite. (D) Movies were analyzed for SG assembly by using 
the standard deviation (StdDev) of the fluorescence intensity of each cell over time. At 
least 240 cells were imaged per cell population (n=3). Slopes were analyzed compared to 
G3BP1-mCherry and statistical analysis was performed using a mixed linear regression 
model (ns = not significant; ****p ≤ 0.0001). (E-F) HeLa G3BP1-mCherry, G3BP1-
mCherry NM-GFPsol and G3BP1-mCherry NM-GFPagg cells were subjected to live cell 
imaging to monitor SG disassembly. Cells were treated with 250 µM sodium arsenite for 1 
h, followed by a medium exchange and subsequent imaging for 3 h. (E) Images taken 
directly (15 min) and 195 min after medium exchange. (F) Movies were analyzed for SG 
disassembly by using the standard deviation (StdDev) of the fluorescence intensity of 
each cell over time. At least 330 cells were imaged per cell population (n=3). Slopes were 
analyzed compared to G3BP1-mCherry and statistical analysis was performed using a 
mixed linear regression model (ns = not significant; *p ≤ 0.05; ****p ≤ 0.0001). 
 
3.5 Treatments that induce SGs also increase induction of NM 
aggregates by recombinant NM fibrils 
It is now emerging that RBPs harboring a LC domain can form pathological 
inclusions, leading to the hypothesis that these inclusions are derived from SGs 
(Aulas and Vande Velde, 2015; Wolozin, 2012). Several in vitro studies showed 
that SG components, such as FUS and hnRNPA1, can phase separate into liquid 
droplets and convert into a more solid state over time (Molliex et al., 2015; Patel 
et al., 2015). Furthermore, it was shown that proteins with disease-linked 
mutations accumulate and aggregate in SGs, thereby altering SG dynamics 
(Mackenzie et al., 2017; Mateju et al., 2017). As the presence of soluble NM 
slightly impaired SG disassembly, we wondered whether the prolonged presence 
of SGs could induce NM prion aggregates. We used HeLa NM-GFP cells and 
treated them with a range of drugs, including some that are known SG inducers. 
Cells were treated with the compounds for 2 h, followed by a medium exchange 
and further cultivation for 22 h (Fig. 20A). Aggregated NM is now termed NM 
aggregate and not prion, as cells were analyzed 24 h after treatment and it cannot 
be ruled out that induced NM aggregates are not of prionogenic nature in this 
experimental setup. Further cultivation of cells treated with SG inducing 
compounds and recombinant fibrils showed that aggregates are passed on to 
daughter cells (data not shown), but as cell death might have falsified results after 
prolonged cultivation, cells were analyzed 24 h after treatment. High-throughput 
imaging was conducted using an automatic confocal microscope (Cell Voyager 
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6000). Analysis showed that only very few cells exhibited aggregates. Further 
inspection of potential NM prion containing cells revealed that the image analysis 
software detected false positives (Fig. 20B). As a positive control, cells were 
treated with 5 µM NM fibrils for 1 h to induce aggregation. The comparison of 
compound treated cells with cells incubated with NM fibrils was used to 
distinguish manually between positive and false positive cells (Fig. 20C).  
 
 
 
Figure 20. NM aggregates cannot be induced by severe stress treatment. (A) 
Schematic diagram of the experiment. HeLa NM-GFP cells were incubated with 
compounds for 2 h, followed by a medium exchange and cultivation for 22 h. Cells were 
subsequently fixed and stained. Images were taken using an automatic confocal 
microscope (Cell Voyager 6000). (B) Analysis of cells with aggregates. HeLa NM-GFP 
cells treated with recombinant NM fibrils are shown as control (red). CHX: Cycloheximide. 
(C) Images of HeLa NM-GFP cells treated with 250 µM arsenite for 2 h (- fibrils) or 
incubated with 5 µM recombinant NM fibrils (+ fibrils), followed by a recovery for 22 h. 
Nuclei were stained with Hoechst and cytoplasm was visualized using CellMask (blue). 
Note that NM-GFP aggregates also brightly stained with Hoechst dye. (D) Analysis of 
total cell number upon different drug treatments (E) Images of HeLa NM-GFP cells 
treated with 250 µM arsenite for 2 h, followed by a recovery for 22 h. SGs were stained 
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with mAb anti-G3BP (red). Nuclei were visualized using Hoechst and cytoplasm was 
stained using CellMask (blue).  
 
Cells treated with SG inducing compounds were severely stressed and underwent 
morphological changes, leading to the condensation of NM-GFP in the cell (Fig. 
20C). The decrease in total cell number further confirmed toxicity of compounds 
(Fig. 20D). Staining of the SG Marker G3BP revealed that some SGs were still 
present after SG induction with arsenite, indicating that our stress treatment led to 
the prolonged presence of SGs (Fig. 20E). Hence, treatment of cells with SG 
inducing compounds led to more persistent SGs, but it did not induce the 
aggregation of NM-GFP. As this experimental setup was already quite toxic to the 
cells, more severe stress, such as longer incubation periods with compounds or 
longer cultivation periods, was not possible. Thus, we conclude that at least in the 
time frame we have tested, NM recruited to SGs cannot turn into an NM prion 
state.  
 
As induction of SGs itself could not lead to the aggregation of NM, we wondered 
whether their presence might influence NM aggregate induction by an exogenous 
seed. HeLa NM-GFP cells were treated with the same compounds as before and 
NM fibrils were added after 1 h treatment, followed by a medium exchange and 
further cultivation (Fig. 21A). To check for SG induction by the used compounds, 
cells were treated for 2 h and subsequently fixed and stained. Analysis showed 
that arsenite and heat shock were the most potent SG inducers (Fig. 21B). This 
was expected as arsenite and heat shock are commonly used to trigger SGs. The 
treatment with MG132 and NaCl led to a good SG response with 40 – 50 % of 
cells harboring SGs. Furthermore, puromycin induced SGs in ~10 % of cells. 
Interestingly, treatment with ER stress inducer thapsigargin did not show induction 
of SGs, although there have been studies in different human cell lines using 
thapsigargin as a SG inducing agent (Arimoto-Matsuzaki et al., 2016; Wheeler et 
al., 2016). Cycloheximide (CHX), salubrinal, rapamycin, wortmannin, and 
tunicamycin did not induce SGs, but were included as controls. CHX and 
salubrinal influence SG assembly positively (salubrinal) or negatively (CHX), while 
tunicamycin induces ER stress without inducing SGs. Rapamycin and wortmannin 
have opposite effects on autophagy, which is a major player in many 
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neurodegenerative diseases and has been shown to play a role in SG clearance 
(Buchan et al., 2013; Mateju et al., 2017). Treatment of HeLa NM-GFP cells with 
the selected compounds and NM fibrils led to increased aggregate induction 
especially in cells treated with SG inducing drugs, compared to the respective 
control (Fig. 21C).  
 
 
 
Figure 21. Presence of stress granules increases aggregate induction. (A) 
Schematic diagram of the experiment. HeLa NM-GFP cells were treated with stress 
inducing compounds for 2 h and 5 µM recombinant fibrillar NM (monomer concentration) 
was added after 1 h of compound treatment. A medium exchange was performed and 
after 16 h cells were fixed and an immunofluorescence staining was conducted. For a SG 
induction control, cells were fixed directly after the 2 h compound treatment. Images were 
taken using the automatic confocal microscope Cell Voyager 6000. (B) Percentage of 
cells with SGs after 2 h treatment with compounds. Bars represent mean values ± SD (n 
= 3). At least 1200 cells were analyzed. Statistical analysis was performed using a logistic 
regression model (ns = not significant; *p ≤ 0.05; ***p ≤ 0.001; ****p ≤ 0.0001). (C) 
Percentage of cells bearing aggregates after treatment with compounds and NM fibrils. 
Bars represent mean values ± SEM (n = 3). Experiment was performed three times in 
triplicates. At least 900 cells were analyzed. Statistical analysis was performed using a 
logistic regression model (ns = not significant; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001). 
 
Cells treated with arsenite showed an induction rate of 40 – 50 % and heat shock 
treatment even led to 80 % of cells harboring aggregates. Treatment with NaCl, 
puromycin, and MG132 led to an aggregate induction in 10 – 15 % of NM-GFP 
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expressing cells. In contrast, control treated cells showed only an induction rate of 
~0.5 – 2 %. The aggregate induction in water and DMSO treated cells was rather 
low, most likely because cells were incubated with fibrils for only 1 h. Additionally, 
we have seen before that aggregate induction is not as efficient with GFP as a 
tag. Interestingly, efficiency of aggregate induction correlated with the amount of 
SG positive cells (Fig. 21B, C). Hence, the presence of SGs seems to have a 
positive effect on NM aggregate induction by exogenous fibrils. 
 
Next, we investigated if SGs positively affect aggregation of NM by functioning as 
the nucleation site. As the concentration of soluble NM is increased inside of SGs, 
the high local concentration could contribute to aggregate induction (Patel et al., 
2015). We performed live cell imaging using HeLa cells expressing mCherry 
tagged G3BP1 and soluble NM-GFP. Cells were treated with arsenite to induce 
SGs and recombinant NM fibrils were added 30 min later (Fig. 22A). Imaging was 
performed for 20 h. Already 1 h post fibril exposure, small NM-GFP aggregates 
were visible, mostly one per cell (Fig. 22B). Surprisingly, the aggregates appeared 
close to but not within SGs (Fig. 22B, inset). As the spatial resolution of a 
widefield fluorescence microscope is limited, we could not rule out that the 
aggregate originated from a SG. To increase resolution and confirm our live cell 
imaging results, we used a confocal microscope equipped with the Airyscan 
technology (Zeiss). The Airyscan technology increases the resolution to 120 nm, 
making it possible to obtain superresolution images with a confocal microscope. 
We used HeLa cells expressing soluble NM-HA, treated them with arsenite to 
induce SGs and added NM fibrils for induction of aggregation. Cells were fixed at 
different time points post fibril exposure to capture the moment of aggregate 
appearance. 5 h after exposure to NM fibrils, numerous small aggregates were 
distributed throughout the cytoplasm (Fig. 22C). However, there was no 
colocalization of NM aggregates with SGs (Fig. 22C, inset). In conclusion, these 
findings show that there is no evidence for SGs acting as nucleation sites for NM 
aggregate formation, neither without nor with an exogenous seed. However, 
treatments that induce SGs, also indirectly affect NM aggregate induction.  
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Figure 22. NM aggregates do not evolve from stress granules. (A) Schematic 
diagram of the experiment. (B) Live cell imaging of HeLa G3BP1-mCherry NM-GFP cells. 
Cells were treated with 50 µM sodium arsenite, followed by addition of 5 µM recombinant 
fibrillar NM (monomer concentration) after 30 min. Imaging was started 30 min after fibril 
exposure and was performed for 20 h. Scale bar: 20 µm (C) HeLa NM-HAsol cells were 
treated with 250 µM sodium arsenite to induce stress granules. After 1 h, 5 µM 
recombinant fibrillar NM (monomer concentration) was added for 1 h, followed by a 
medium exchange. Cells were fixed 5 h post fibril induction and immunofluorescence 
staining was performed using mAb anti-HA (green) and mAb anti-G3BP (red). Nuclei 
were stained with Hoechst (blue). Scale bar: 10 µm. Images were captured using the 
LSM 800 equipped with an Airyscan. 
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3.6 The physical appearance of SGs is not important for an increased 
induction rate of NM aggregation 
The foregoing experiments demonstrated that treatments that induce SGs also 
increase induction of NM aggregates, despite the fact that we did not observe 
seeding of NM aggregates by SGs. To further investigate the role of SGs in the 
induction of aggregates with NM fibrils, we inhibited SG assembly. So far SG 
inhibition has mainly been achieved by the depletion of SG nucleating factors 
(Bley et al., 2015; Matsuki et al., 2013). The combined knockdown of TIA-1, TIAR, 
and G3BP most efficiently reduces the number of visible SGs without affecting 
stress signaling (Bley et al., 2015). Hence, we transfected HeLa cells with a 
siRNA mix targeting TIA-1, TIAR and G3BP and analyzed the SG induction rate 
(Fig. 23A, B). The concomitant knockdown of TIA-1, TIAR, and G3BP severely 
impaired the formation of SGs and reduced the number of SG-positive cells to 
~20 %.  
 
 
 
Figure 23. Knockdown of G3BP efficiently inhibits SG formation. (A) HeLa cells were 
transfected with either non-silencing siRNA (NS) or a siRNA mix targeting TIA-1, TIAR 
and G3BP (3xKD). 72 h post transfection, cells were treated with 0.5 mM arsenite for 1 h, 
subsequently fixed and immunofluorescence staining was performed using pAb anti-
FMRP (green). Nuclei were stained using Hoechst (blue). Images were obtained using 
the automatic confocal microscope Cell Voyager 6000. (B) Analysis of cells harboring 
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SGs 72 h post siRNA transfection. Bars represent mean values ± SD (n = 3). Statistical 
analysis was performed using unpaired two-tailed Student’s t-test (****p ≤ 0.0001). (C) 
HeLa cells were transfected with siRNA targeting G3BP, TIA-1, or TIAR. Non-silencing 
(NS) siRNA was used as control. 72 h post transfection, cells were treated with 0.5 mM 
arsenite for 1 h, subsequently fixed and immunofluorescence staining was performed 
using pAb anti-FMRP (green). Nuclei were stained using Hoechst (blue). Images were 
obtained using the automatic confocal microscope Cell Voyager 6000. (D) Analysis of 
cells harboring SGs 72 h post siRNA transfection. Bars represent mean values ± SD (n = 
3). Statistical analysis was performed using one-way ANOVA with Dunnett’s multiple 
comparisons test (ns = not significant; ****p ≤ 0.0001). 
 
Cells showed almost no toxicity after the triple knockdown. However, the SG 
inducing treatment we wanted to conduct was already quite toxic to cells without 
siRNA transfection (Fig. 20C, D). Therefore, we wanted to test if the knockdown of 
a single SG factor would give a similar reduction in SG positive cells. HeLa cells 
were transfected with siRNA targeting TIA-1, TIAR, or G3BP alone and 72 h post 
transfection, cells were analyzed for SG induction after treatment with arsenite. 
Surprisingly, the knockdown of G3BP already led to a reduction of SG positive 
cells to ~20 %, comparable to the triple knockdown (Fig. 23C, D). No significant 
impairment of SG formation could be detected upon knockdown of TIA-1 and 
TIAR. Thus, depletion of G3BP substantially impaired the formation of visible SGs 
and was used for further experiments. 
 
To investigate the effect of SG inhibition on aggregate formation induced by 
exogenous NM fibrils, HeLa NM-GFP cells were transfected with siRNA targeting 
G3BP. 72 h post transfection, cells were incubated with compounds and after 1 h 
NM fibrils were added for 1 h (Fig. 24A). The medium was exchanged for further 
cultivation and cells were analyzed the next day for aggregate induction. 
Knockdown efficiency was confirmed by immunofluorescence and western blot 
analysis (Fig. 24B, C). The effect of G3BP knockdown on SG assembly was 
assessed for all compounds by immunofluorescence staining 2 h after drug 
treatment (Fig. 24D). SG formation was significantly decreased in arsenite, 
puromycin, heat shock, and MG132 treated cells after depletion of G3BP. 
Interestingly, there was almost no effect on SG formation in NaCl treated cells. It 
has been shown that macromolecular crowding regulates the assembly of SGs 
upon osmotic stress (Bounedjah et al., 2012). Hence, knockdown of G3BP does 
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not seem to play a role in this pathway of SG assembly. For most cells, treated 
with drugs that do not induce SGs, a significant difference between non-silencing 
(NS) and knockdown of G3BP (KD) was detectable even though the total 
numbers of SG-positive cells were very low and varied only slightly between NS 
and KD conditions. This is a result from the high amount of cells used for analysis 
and is not relevant for our study. Hence, SG formation was efficiently inhibited for 
most SG inducing compounds. 
 
 
 
Figure 24. Inhibition of stress granule assembly by siRNA has no effect on 
aggregate induction. (A) Schematic diagram of the experiment. HeLa NM-GFP cells 
were transfected with siRNA against G3BP (KD) or non-silencing (NS) siRNA for 72 h 
before treatment. Stress inducing compounds were added and after 1 h cells were 
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exposed to 5 µM recombinant fibrillar NM (monomer concentration). The medium was 
exchanged after 1 h and cells were either fixed directly, to serve as the SG induction 
control, or further cultivated for 16 h. (B) Immunofluorescence staining was performed 
after 2 h treatment with 250 µM sodium arsenite using pAb anti-FMRP (green). Nuclei 
were stained with Hoechst (blue). (C) Analysis of KD efficiency was performed via 
western blot 72 h post transfection. G3BP was detected by mAb anti-G3BP, actin was 
detected using mAb anti-actin. The experiment was performed in triplicates. NS signal 
was set to 100 %. Bars represent mean values ± SD. Statistical analysis was performed 
using unpaired two-tailed Student’s t-test (****p ≤ 0.0001). (D) Percentage of cells with 
SGs after 2 h treatment with compounds. Bars represent mean values ± SD (n = 3). At 
least 500 cells were analyzed per compound and biological replicate. Statistical analysis 
was performed using a logistic regression model (ns = not significant; **p ≤ 0.01; ****p ≤ 
0.0001). (E) Percentage of cells bearing aggregates after treatment with compounds and 
NM fibrils. Bars represent mean values ± SEM (n = 3). Experiment was performed three 
times in triplicates. At least 1100 cells were analyzed per compound and biological 
replicate. Statistical analysis was performed using a logistic regression model (****p ≤ 
0.0001).  
 
Treating cells with compounds and NM fibrils resulted in similar aggregate 
induction rates between NS and KD (Fig. 24E). The SG inducing compounds 
arsenite and MG132 showed a slightly increased number of cells with aggregates 
upon SG inhibition, whereas for NaCl, puromycin, and heat shock treated cells a 
reduction in aggregate induction was detectable. As shown before, SG inducing 
compounds were quite toxic to the cells (Fig. 20D), suggesting that the detected 
differences between NS and KD are not biologically relevant. However, there was 
a significant increase in aggregate induction upon G3BP knockdown for 
compounds not inducing SGs (Fig. 24E). Control treated cells (H2O and DMSO) 
showed a 5-fold, salubrinal treated cells even a 12-fold increase in aggregate 
induction. Hence, knockdown of G3BP and the concomitant inhibition of SG 
assembly increased the aggregate induction rate upon treatment with non-SG 
inducing compounds. The effect seemed to be abolished upon activation of SG 
stress signaling. 
 
To further investigate the effect of G3BP knockdown on the induction of NM 
aggregation, we had a closer look at autophagy. Autophagy is a degradative 
process that clears the cell of damaged organelles and aggregated proteins. In 
neurodegenerative diseases, autophagy plays a major role, especially as 
therapeutic target (Nixon, 2013). Moreover, autophagy has been implicated to 
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facilitate the clearance of SGs (Buchan et al., 2013). Hence, we tested whether 
the knockdown of G3BP had an effect on aggregate induction by altering 
autophagy. To examine the autophagic flux upon G3BP knockdown, we treated 
HeLa cells with chloroquine. Chloroquine inhibits the fusion of autophagosomes 
with lysosomes, leading to the accumulation of autophagy markers. Western blot 
analysis showed that upon chloroquine treatment, p62 and LC3-II were markedly 
increased (Fig. 25A). LC3-II serves as an autophagy marker as during autophagy 
the cytosolic form of LC3 (LC3-I) is conjugated to phosphatidylethanolamine (PE) 
to form LC3-PE (LC3-II), which is recruited to autophagosomal membranes 
(Tanida et al., 2008). P62 binds ubiquitinated proteins, and targets them to 
autophagosomes, thereby facilitating their clearance (Bjorkoy et al., 2009). 
Quantitative analysis of LC3-II and p62 signal showed that there was no 
significant difference between G3BP knockdown and non-silencing control (Fig. 
25B, C). Hence, increased aggregate induction through G3BP knockdown is not 
facilitated by autophagy. 
 
 
 
 
Figure 25. Knock down of G3BP does not induce autophagy. (A) HeLa NM-GFP cells 
were transfected with siRNA against G3BP (KD) or non-silencing (NS) siRNA. After 54 h, 
10 µM chloroquine (CQ) or H2O was added to cells for 16 h. Western blotting was 
performed using mAb anti-p62 and mAb-LC3A/B. Actin served as a loading control. (B-C) 
Quantification of LC3-II (B) and p62 (C) signals. Statistical analysis was performed using 
unpaired two-tailed Student’s t-test (ns = not significant). 
 
As inhibition of SGs by knockdown of G3BP causes additional effects by the 
depletion of G3BP, we tried to inhibit SG assembly in a different way. 
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Phosphorylation of eIF2α is an essential player in the upstream regulation of SG 
assembly. Four different kinases regulate the phosphorylation of eIF2α upon 
stress signals: PERK (ER stress), PKR (dsRNA, antiviral defense), GCN2 (amino 
acid starvation) and HRI (heme deficiency) (Jiang and Wek, 2005). Inhibition of 
PERK by the compound GSK2606414 has been shown to reduce arsenite and 
MG132 induced SG formation (Cheng et al., 2018). Hence, we used the PERK 
inhibitor GSK2606414 to inhibit SG assembly, followed by SG and aggregate 
induction (Fig. 26A).  
 
 
 
Figure 26. Inhibition of eIF2α phosphorylation and stress granule assembly has no 
effect on aggregate induction. (A) Schematic diagram of the experiment. HeLa NM-
GFP cells were pre-treated with GSK2606414 or DMSO for 1 h. Arsenite was added and 
after 1 h, cells were exposed to 5 µM recombinant fibrillar NM (monomer concentration). 
The medium was exchanged after 1 h and cells were either fixed directly, to serve as the 
SG induction control, or further cultivated for 16 h. Immunofluorescence staining was 
performed using mAb anti-G3BP. (B) Immunofluorescence staining of HeLa cells pre-
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treated with GSK2606414 or DMSO for 1 h and SG inducing treatment with 250 µM 
sodium arsenite for 2 h. SGs were stained using mAb anti-G3BP (green). Nuclei were 
stained with Hoechst (blue). (C) Percentage of cells with SGs after 2 h treatment with 
arsenite. Bars represent mean values ± SD (n = 3). At least 900 cells were analyzed per 
treatment and biological replicate. Statistical analysis was performed using a logistic 
regression model (**p ≤ 0.01; ****p ≤ 0.0001). (D) Percentage of cells bearing NM-GFP 
aggregates after treatment with arsenite and NM fibrils. Bars represent mean values ± SD 
(n = 3). At least 1200 cells were analyzed per treatment and biological replicate. 
Statistical analysis was performed using a logistic regression model (ns = not significant; 
**p ≤ 0.01). 
 
We focused on arsenite as SG inducing agent since treatment with arsenite 
resulted in a robust SG induction that could be inhibited by G3BP knockdown 
(Fig. 24B, C). First, HeLa cells were tested for the ability of GSK2606414 to inhibit 
SG formation. HeLa cells were pre-treated with GSK2606414 or DMSO for 1 h, 
followed by addition of arsenite for 2 h (Fig. 26B, C). Immunofluorescence 
staining was performed and showed that GSK2606414 efficiently inhibited the 
assembly of SGs (Fig. 26B). Image analysis revealed that GSK2606414 
significantly reduced SG positive cells to ~20 % (Fig. 26C). Interestingly, induction 
of NM aggregation with exogenous fibrils resulted in no significant difference 
between GSK2606414 and DMSO treated cells upon arsenite treatment (Fig. 
26D). Thus, inhibition of SG assembly by inhibition of eIF2α phosphorylation has 
no effect on induction of NM aggregates. In conclusion, these findings show that 
neither the physical appearance of SGs nor eIF2α phosphorylation, or its 
downstream pathway are the reason for the increased aggregate induction upon 
treatment with SG inducing compounds. 
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4. Discussion 
The cellular environment is shaped by numerous membrane-less compartments, 
which influence biological reactions through the condensation of proteins and 
nucleic acids. These compartments appear to assemble via intracellular phase 
transition, thereby forming a dense network of multiple weak interactions (Shin 
and Brangwynne, 2017). RBPs are a major component of membrane-less 
compartments, enabling phase transition by their LCDs or PrLDs. Interestingly, 
many RBPs are part of pathological inclusion that can be found in degenerative 
disorders. Especially RBPs harboring mutations in their PrLD have been 
implicated with disease (Johnson et al., 2009; Mackenzie et al., 2017; Patel et al., 
2015). Several observations led to the hypothesis that these pathological protein 
inclusions are derived from membrane-less organelles. Here we investigated the 
correlation between stress granules, a cytosolic membrane-less compartment, 
and prion aggregates. Using the yeast prion domain NM of Sup35 as a model for 
cytosolic protein aggregation, we show that induction of persistent SGs is not 
sufficient to induce NM aggregates. The prolonged presence of SGs often 
resulted in cell death, indicating that SGs rather trigger cell death than evolve into 
pathological protein aggregates. However, chemical SG induction concomitant 
with NM aggregate induction by recombinant fibrils led to a severe increase in NM 
aggregate formation. Interestingly, this increase in aggregation was not abolished 
upon SG inhibition, arguing that other processes than the formation of SGs must 
be involved. 
 
4.1 Stress granules and NM prions have a comparable interactome 
SGs are involved in RNA metabolism by sequestering mRNA transcripts during 
stress situations, thus their proteome is enriched for proteins with RNA-binding 
activity. Furthermore, the SG proteome harbors many proteins that contain LCDs, 
especially PrLDs (Jain et al., 2016; Markmiller et al., 2018). Interestingly, the 
interactomes of SG proteins remain largely unchanged in non-stress and stress 
conditions (Youn et al., 2018). The interactomes of soluble and aggregated NM 
show a significant overlap with the SG proteome while also being enriched for 
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proteins involved in RNA metabolism and containing PrLDs (Fig. 8). The feature 
analysis of the NM and SG proteomes revealed enrichment for intrinsically 
disordered and nucleic acid binding proteins, further highlighting the similarities of 
these interactomes. Interestingly, the interactomes of soluble and aggregated NM 
appear very similar, although aggregated NM has almost 10 times more unique 
hits than soluble NM. In addition to proteins that are part of the RNA metabolism, 
aggregated NM recruited several proteins involved in protein degradation 
pathways, including proteins participating in degradation via autophagy and the 
ubiquitin-proteasome system (UPS). Autophagy and the UPS are the major 
proteolytic systems of eukaryotic cells. Ubiquitinated proteins are predominantly 
degraded via the UPS, whereas aggregated proteins are mostly directed to 
autophagic degradation. Aggregated proteins are targeted by autophagy 
adaptors, such as p62 and NBR1, which bind to misfolded proteins and deliver 
them to the autophagosome for lysosomal degradation (Cha-Molstad et al., 2015). 
P62 decorated NM prions, suggesting that they are recognized as misfolded 
proteins and targeted for degradation via autophagy. However, NM prions are 
faithfully transmitted to daughter cells and maintained over multiple passages, 
indicating that the cell is not able to fully degrade NM prions (Hofmann et al., 
2013; Krammer et al., 2009). Similar to the interactome of aggregated NM, the SG 
proteome of neurons exhibits several proteins that function in autophagy 
(Markmiller et al., 2018). Autophagy has been suggested to play a role in SG 
clearance, indicating that SGs are monitored by autophagy factors (Buchan et al., 
2013; Mateju et al., 2017). Hence, NM prions and SGs interact with similar 
proteins, which might be the first hint for a correlation between these two 
assemblies. 
 
RNA is an important component of SGs, as their function is the sequestration and 
storage of mRNA transcripts. Analysis of the SG transcriptome revealed that SGs 
accumulate mostly diverse mRNAs and some noncoding RNAs (ncRNAs), with 
essentially every mRNA present to some extent (Khong et al., 2017). 
Interestingly, SGs contain only ~10% of total mRNA, leading to the suggestion 
that SGs may not have a large effect on global mRNA (Khong et al., 2017). 
However, RNA is important for SG assembly, as treatment with polysome 
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stabilizing drugs inhibits SG formation (Kedersha et al., 2000). We identified RNA 
as a component of NM prions, but did not further analyze the transcriptome or its 
role in aggregate formation. The sequestration of RNA to NM prions could occur 
by different mechanisms: RNA-binding might be a secondary effect by binding to 
recruited RBPs. Alternatively, RNA might bind directly to NM. Although NM does 
not harbor an RNA-binding motif, the intrinsically disordered PrD of NM could 
facilitate RNA-binding, as these domains were shown to bind RNA (Jarvelin et al., 
2016). RNA has already been implicated in neurodegenerative diseases in 
different ways. In vitro, RNA has been shown to accelerate aggregation of a 
variety of proteins, including tau and PrP (Deleault et al., 2003; Kampers et al., 
1996). Hence, the presence of free RNA might increase protein aggregation or 
decrease the threshold for this process in the cell or in SGs. Furthermore, the 
sequestration of RNA by protein aggregates might alter RNA processing that is 
required for normal cellular functions. Especially in neurodegenerative diseases 
where RBPs, such as TDP-43 and FUS, are accumulating, loss of RNA-
dependent functions might contribute to pathology. Understanding the role of RNA 
in neurodegenerative disorders might help to elucidate the pathogenic 
mechanisms of RBP inclusions and other protein aggregates that sequester RNA. 
 
4.2 Similar subdomains of N are required for binding to NM prions and 
SGs 
SGs form by multiple weak interactions between proteins and RNAs. Thereby, 
RBPs bind to RNA through RRMs or other RNA-binding domains and further 
assemble into a dense network by engaging in protein-protein interactions 
through specific binding motifs or low complexity domains. Treatment with the 
aliphatic alcohol 1,6-hexanediol, which is hypothesized to disrupt weak 
hydrophobic interactions, disassembles SGs, indicating that hydrophobic 
interactions are a key component in the SG network (Kroschwald et al., 2015; 
Patel et al., 2007). Furthermore, SGs are dynamic structures, with their 
components being in a constant exchange with the surrounding cytosol. However, 
it is currently not known how specificity of SGs is generated and maintained. 
Direct protein-protein interactions may provide specificity, together with additional 
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features, such as number and spacing of binding motifs or post-translational 
modifications. In contrast to SGs, pathological protein inclusions often exhibit an 
amyloid structure, which is highly ordered and resistant to degradation. These 
inclusions contain mainly one protein that forms unbranched fibers consisting of 
β-strands. In mammalian cells, NM prions most likely have an amyloid structure 
as shown by SDD-AGE and seen by immuno electron microscopy, where staining 
of NM-HA in N2a NM-HAagg cells revealed fibrillar structures (in collaboration with 
Al-Amoudi, unpublished). Interestingly, similar subdomains of N are involved in 
the binding of NM to the rather loose network of SGs and to highly ordered NM 
prions. Furthermore, the binding of NM to SGs is specific, as no recruitment of NM 
to P bodies, which is a closely to SGs related membrane-less organelle, was 
observed. For recruitment of NM to pre-existing NM prions, the carboxyterminal 
part of the N domain, comprising the last three repeats of the OPR and the CTN, 
were identified as the preferential binding sites in mammalian cells (Duernberger 
et al., 2018). The CTN was identified as the amyloid core and nucleation site, and 
being most important for de novo aggregate induction. Hence, in mammalian cells 
the last three repeats of the OPR and the CTN facilitate conversion into the 
aggregated form. Similar domains preferentially drove recruitment to SGs, namely 
the OPR and the CTN (Fig. 27).  
 
 
Figure 27. Similar domains drive recruitment of NM protein to NM prions and SGs. 
NM can be sequestered to NM prions and SGs. The subdomains of NM that are 
important for the recruitment to these assemblies are shown below, marked by a red 
rectangular. The position of regions and their lengths are shown in number of amino 
acids. QNR: Asparagine- and glutamine- rich region; OPR: Oligopeptide repeat region; 
CTN: Carboxyterminal N domain. 
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However, the size of the deletion had an effect on recruitment of NM to SGs, with 
larger deletions resulting in less efficient recruitment (Fig. 14). Furthermore, no 
deletion of any N subdomain totally abolished the recruitment of NM to SGs, 
suggesting that binding of NM to SGs is probably facilitated by multiple 
interactions with SG components and not by a single subdomain of N. Thereby, 
NM could bind to proteins through its PrD, as interactions between intrinsically 
disordered domains have been shown to contribute to SG assembly (Boeynaems 
et al., 2018; Gilks et al., 2004). The PrD of NM is enriched in glutamine and 
asparagine residues, which were shown to promote aggregation (Alberti et al., 
2009; DePace et al., 1998; Michelitsch and Weissman, 2000). Furthermore, Q/N-
rich PrLDs of SG proteins are important for recruitment to SGs, indicating that 
regions enriched in glutamine and asparagine can facilitate binding to SGs 
(Bentmann et al., 2012; Gilks et al., 2004). The QNR shows the highest Q/N 
content but its deletion only slightly affected recruitment to SGs (Fig. 28). 
However, also the carboxyterminal N domain displays a high Q/N content while 
being most important for binding to SGs. Hence, glutamine and asparagine 
residues could play a role in both, prion formation and the recruitment of NM to 
SGs. However, for binding to SGs additionally the OPR was important. Thus, 
other features than Q/N-rich regions seem to be relevant. A recent study 
suggested that interactions between tyrosine-rich and arginine-rich regions can 
facilitate phase separation, a process that is thought to describe SG formation 
(Wang et al., 2018). The N domain and especially the OPR are enriched for 
tyrosine residues, which could facilitate recruitment to SGs by binding to arginine-
rich regions of other proteins. Furthermore, the OPR is enriched for glycine 
residues, which might act as a spacer and provide conformational flexibility as 
glycine residues have been suggested to maintain the liquid-like state of liquid 
droplets by increasing the flexibility of the molecules (Wang et al., 2018). Through 
the presence of spacers within the N domain, flexible binding of subdomains to 
multiple proteins might be facilitated. Hence, different interactions of N with SG 
components might play a role in recruitment of NM to SGs, facilitated by distinct 
residues or subdomains within the N domain. Additionally, intrinsically disordered 
regions have recently been identified to mediate RNA-binding, suggesting that 
NM might also be recruited to SGs by binding to RNA (Jarvelin et al., 2016). The 
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fact that similar subdomains, namely the carboxyterminal N domain, facilitate the 
binding of NM to preexisting NM prions and SGs, supports the hypothesis that 
there is a correlation between these two assemblies. 
 
 
 
Figure 28. Amino acid composition of regions within the N domain of Sup35. The 
position of regions and their lengths are shown in number of amino acids. The abundance 
of single amino acids is depicted in percent. 
 
4.3 NM prion induction is independent of eIF2α phosphorylation  
Exposure of cells to stress conditions leads to an arrest of global translation to 
save energy. In many cases, translational inhibition is facilitated by 
phosphorylation of eIF2α as part of the integrated stress response. 
Phosphorylation of eIF2α reduces translation initiation and results in naked 
mRNAs, as ribosomes run off their transcripts. Free mRNA transcripts then bind 
to RBPs and are further assembled into SGs. Most SG inducing treatments 
require phosphorylation of eIF2α for SG formation, except for osmotic stress, 
where eIF2α phosphorylation is a secondary effect to mediate apoptosis 
(Bevilacqua et al., 2010). Hence, phosphorylation of eIF2α plays a major role in 
the cellular response to stress. Induction of NM aggregation by treatment with 
recombinant fibrils showed no phosphorylation of eIF2α, indicating that the stress 
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response is not triggered. Furthermore, inhibition of PERK, one of four kinases 
that is responsible for eIF2α phosphorylation, had no effect on NM aggregate 
induction. Hence, SGs and NM prions do not share this common pathway for their 
induction. This indicates that formation of NM prions by induction with an 
exogenous seed most likely does not involve the concomitant induction of SGs.  
 
4.4 Stress granule dynamics are not altered by presence of NM 
SGs are dynamic structures that have liquid-like properties. Upon exposure to 
stress, SGs rapidly assemble, merge over time to form larger structures and relax 
into spherical assemblies after fusion (Kroschwald et al., 2015). SG proteins, such 
as TIA-1 and G3BP, have a fast turnover inside SGs and with the surrounding 
cytosol (Kedersha et al., 2000; Kedersha et al., 2005; Kroschwald et al., 2015). 
The presence of misfolded proteins within SGs can alter the dynamic properties of 
SGs, as shown for SOD1 (Mateju et al., 2017). Furthermore, defective ribosomal 
products (DRiPs), prematurely terminated polypeptides, accumulate within SGs 
and change their dynamics and disassembly rate (Ganassi et al., 2016). However, 
cells have developed a surveillance system to remove misfolded proteins or 
DRiPs from SGs to ensure their liquid-like state. Chaperones constantly monitor 
SGs to target misfolded proteins for degradation, preventing the formation of 
aberrant SGs (Ganassi et al., 2016; Mateju et al., 2017). Hence, an active and 
efficient protein quality control (PQC) ensures SG dynamics. The presence of 
soluble or aggregated NM had no effect on SG dynamics as assessed by FRAP 
analysis of G3BP, indicating that NM does not alter the state of SGs. However, 
SG assembly and disassembly rates were slightly delayed in cells harboring NM 
prions and also soluble NM had an effect on SG disassembly. SG disassembly 
has been proposed to be a multi-step process, where first large SGs break into 
smaller foci, followed by their clearance (Wheeler et al., 2016). Chaperones, such 
as HSP70, and autophagy have been shown to play a role in dissolving SGs 
(Buchan et al., 2013; Mateju et al., 2017). Aberrant SGs are transported towards 
the aggresome, a perinuclear structure that sequesters misfolded proteins, for 
autophagic degradation (Fortun et al., 2003; Johnston et al., 1998; Mateju et al., 
2017). The presence of NM in SGs might increase the workload of the SG 
clearance system as SGs need be transported towards the aggresome for 
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degradation, causing the delay. Furthermore, SG dynamics might be altered by 
the prolonged presence of NM within SGs and components could change over 
time. Though, it is not clear how long the remaining SGs persisted in the presence 
of NM and which effect persistent SGs have on the cell. 
 
4.5 SG induction is not enough to induce aggregation of NM 
Over the last years, the hypothesis that SGs contribute to disease pathology has 
been raised. It has been suggested that the persistence of SGs triggers the 
conversion of disease-associated proteins present in SGs into pathological 
protein aggregates. Evidence for this hypothesis mainly comes from in vitro 
studies, which showed that SG components can form liquid droplets, which in 
some cases adopt a gel-like or even fibrous state (Molliex et al., 2015; Patel et al., 
2015). Many proteins can form liquid droplets above their saturation concentration 
in vitro, leading to a higher concentration of the protein within the droplet and a 
concomitant reduction in the surrounding cytosol (Shin and Brangwynne, 2017). 
Hence, by increasing the concentration of proteins in liquid compartments, their 
aggregation might be triggered. In vivo and in vitro studies already showed for 
FUS that increasing the concentration can cause a conversion of the protein into 
an aggregated state (Patel et al., 2015; Shelkovnikova et al., 2014; Sun et al., 
2011). Hence, the local increase in concentration that occurs in membrane-less 
organelles might serve as nucleation site for the conversion of aggregation-prone 
proteins into pathological isoforms. Further evidence for a connection between 
SGs and protein aggregates came from patient biopsies of several degenerative 
diseases that harbored protein inclusions containing SG components, suggesting 
SGs as the starting point of aggregate formation (Hackman et al., 2013; Liu-
Yesucevitz et al., 2010). In cell culture, disease-associated mutations in RBPs 
were shown to alter SG dynamics and to delay SG disassembly (Mackenzie et al., 
2017; Mateju et al., 2017). However, SG disassembly was only monitored for a 
few hours and as long as SGs persisted. If SGs were eventually disassembled or 
how the cell responded was not stated. In our experiments, prolonged or severe 
treatment with SG inducing drugs could not induce NM aggregates, but rather led 
to cell death. Although some SGs were still present after 24 h, the conversion of 
NM into its prion isoform was not triggered or was prevented. Interestingly, a 
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recent study argued against a conversion of persistent SGs into protein 
aggregates by showing that the cytoplasmic translocation of FUS is independent 
of SG assembly and that FUS can escape persistent SGs (Hock et al., 2018). 
Furthermore, they suggested that the nuclear import receptor TNPO1 might 
function as a chaperone to prevent aberrant phase transition of FUS. Additionally, 
several other studies showed that nuclear import receptors can function as 
chaperones to counteract aggregation of RBPs (Guo et al., 2018; Hofweber et al., 
2018; Qamar et al., 2018; Yoshizawa et al., 2018). Hence, the cell has developed 
efficient ways to combat protein misfolding in SGs by the surveillance with 
chaperones and degradation of aberrant SGs by autophagy (Mateju et al., 2017). 
As in SGs aggregation-prone proteins are abundant, cells will monitor this 
process closely to keep proteins from aggregating or to remove and degrade 
misfolded proteins. Maybe SGs even sequester aggregation-prone proteins to 
keep them from aggregating during times of stress by holding them in one place 
that is closely monitored. Posttranslational modification enzymes are part of SGs 
and might play a part in regulating aggregation-prone proteins. Protein 
phosphorylation, methylation and glycosylation were already shown to influence 
SG assembly (Goulet et al., 2008; Ohn et al., 2008; Tourriere et al., 2003). For 
TDP-43 it has been suggested that its localization to SGs prevents stress-induced 
phosphorylation and the concomitant aggregation of TDP-43 (McGurk et al., 
2018). However, aging might be a risk factor for membrane-less organelles. Aging 
leads to reduced autophagic activity, as shown by downregulation of some 
proteins involved in autophagy in the human brain (Lipinski et al., 2010). Impaired 
autophagy has already been implicated with several neurodegenerative diseases, 
including Alzheimer’s disease, Parkinson’s disease, and Huntington disease 
(Menzies et al., 2017; Menzies et al., 2015). Also in ALS, mutations in a range of 
autophagy related proteins have been identified that cause autophagic 
dysregulation (Gal et al., 2009; Shen et al., 2015; Teyssou et al., 2013). In 
cultured cells, mutations in VCP or inhibition of HSP70 led to reduced clearance 
of SGs, suggesting that an impaired protein degradation system can cause the 
persistence of SGs (Buchan et al., 2013; Mateju et al., 2017). Furthermore, 
posttranslational modifications influence SG assembly and disassembly. SG 
dissolution is promoted by phosphorylation of the SG protein Grb7 and the 
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activation of DYRK3 kinase (Tsai et al., 2008; Wippich et al., 2013). The casein 
kinase 2 (CK2) was shown to regulate SG disassembly by phosphorylating the 
key SG component G3BP (Reineke et al., 2017). Posttranslational modifications 
represent an additional and important factor in the regulation of SG disassembly. 
Hence, SG disassembly represents a complex mechanism that is influenced by 
multiple factors. Numerous modulations can lead to persistence of SGs, but the 
influence of persistent SGs on cells is not known. Our data suggest that persistent 
SGs rather trigger cell death than protein misfolding. SG formation comes along 
with a global translational arrest and influences multiple cellular functions by the 
sequestration of proteins. Furthermore, it is not known whether SGs actually play 
a role in vivo. Using hyperthermia to induce stress in live mice, neurons were 
shown to exhibit cytoplasmic foci positive for TIAR and mRNA, most likely 
representing SGs (Shelkovnikova et al., 2017). However, neurons failed to 
assemble SGs upon elevated levels of phosphorylated eIF2α due to mutant tau, 
suggesting that chronic phosphorylation of eIF2α is deleterious to neurons due to 
impaired SG integrity. Only few studies were conducted using primary cells, 
including neurons, astrocytes, and glia cells, showing that the SG response is 
variable dependent on the cell type and stress conditions (Dewey et al., 2011; 
Khalfallah et al., 2018; Shelkovnikova et al., 2017). Neurons failed to assemble 
SGs upon osmotic stress and were more resistant to SG induction by arsenite, 
indicating that neurons are refractory to a certain extent to stress (Khalfallah et al., 
2018). By contrast, another study using organotypic brain slices showed that SGs 
were triggered in neurons upon oxidative and osmotic stress (Hock et al., 2018). 
The SG response seems to be very different depending on the cell type, the 
stress conditions or experimental setup, indicating that the stress response is a 
complex mechanism. Whether the CNS reacts to stress by formation of SGs 
remains to be further investigated. 
 
4.6 SG induction increases NM aggregation by exogenous seeds 
Prolonged presence of SGs did not induce the aggregation of NM in our 
experimental setup. However, NM aggregate induction by recombinant fibrils was 
drastically increased in cell populations that contained chemically induced SGs. 
NM aggregate formation efficiency correlated to a certain degree with the number 
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of cells harboring SGs. during addition of fibrils. Stress inducing drugs that did not 
result in SG formation, such as the ER stress inducers tunicamycin or 
thapsigargin, had only minor effects on aggregate formation. Surprisingly, genetic 
or chemical inhibition of SG formation had no effect on the increased NM 
aggregate induction, arguing that the increased concentration of NM within SGs is 
not the reason for higher aggregate formation. Inhibition of SG formation was 
accomplished by two different mechanisms: genetically by siRNA knockdown of a 
SG component that is important for SG assembly, or pharmacologically by PERK 
inhibition, which abolishes phosphorylation of eIF2α. Both efficiently inhibited SG 
formation, demonstrating that the increased NM aggregate induction is not 
dependent on SG assembly downstream of eIF2α phosphorylation. Also 
superresolution microscopy did not reveal SGs as nucleation sites for aggregate 
induction by exogenous seeds. However, the presence of small, microscopically 
undetectable SGs or SG precursors upon SG inhibition, or small aggregates 
originating from SGs, cannot be ruled out. Youn and coworkers argue that 
submicroscopic SGs are already present in unstressed cells to serve as seeds for 
a rapid SG assembly upon stress conditions (Youn et al., 2018). These seeds 
most likely represent mRNP particles, which would also be present upon SG 
inhibition and could affect NM aggregation during stress conditions. As SG 
inhibition targeted two different steps of SG assembly, the signal responsible for 
the increased aggregate induction rate has to be further upstream in the SG 
induction pathway. SG induction might lead to the activation of the PQC and the 
subsequent recruitment of chaperones to mRNP particles to assist SG formation. 
Upon concomitant aggregate induction, chaperones would be occupied and could 
not combat aggregate formation. Treatment with SG inducing agents might 
activate chaperones in a stress-dependent manner, without the need of 
transcription. In bacteria several stress-inducible chaperones have already been 
identified, which use unfolding or oxidation for activation, but only few eukaryotic 
chaperones are known that can be directly activated by stress (Voth and Jakob, 
2017). Under non-stress conditions, these proteins most likely have a different 
function and only exhibit chaperone-like activities upon stress. A chaperone 
function has already been attributed to several nuclear import receptors, which 
keep proteins containing a nuclear localization signal from aggregating in the 
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cytosol (Guo et al., 2018; Hofweber et al., 2018; Qamar et al., 2018; Yoshizawa et 
al., 2018). Further investigations are needed to identify unknown chaperones and 
to elucidate the role of chaperones in response to SG induction. 
 
4.7 The correlation between stress granules and protein aggregates 
Some studies found SG proteins as part of pathological protein inclusions in 
patient biopsies, suggesting that protein inclusions are derived from SGs (Liu-
Yesucevitz et al., 2010; Vanderweyde et al., 2012). In our study, NM prions also 
exhibited a similar interactome than SGs, indicating that both assemblies are 
somehow related. However, we could not show that NM aggregates were induced 
by SG induction or evolved out of SGs. SGs were also not observed during 
aggregate induction by recombinant fibrils. Hence, there must be another 
explanation for the sequestration of SG proteins to NM prions. SG proteins might 
be recruited to NM prions by interactions between their LCDs and the PrD of NM, 
as the PrD mediates binding to SGs. This might also be the case for protein 
inclusions of TDP-43 and FUS, which can be found in some cases of ALS and 
FTLD. Furthermore, SG proteins could be sequestered to inclusions by binding to 
RNA, which is part of protein aggregates. Hence, the presence of SG proteins in 
protein inclusions can be explained in several ways. Although many in vitro 
studies over the last years suggest an involvement of persistent SGs in the 
formation of protein aggregates, only very few studies investigate this hypothesis 
in cell culture or even in vivo. The cell has developed an effective PQC system 
that combats protein misfolding and will especially monitor processes, which 
involve regulated protein aggregation such as the formation of SGs. Sequestering 
aggregation-prone proteins in SGs upon stressful conditions might be a way to 
actually keep proteins from misfolding by holding them together for surveillance. 
However, a defective or overwhelmed PQC might not be able to counteract 
protein misfolding and aggregation. The concomitant induction of SGs and NM 
aggregates by recombinant fibrils led to a drastically increased formation of NM 
aggregates. As treatment with other stress inducing drugs that did not result in SG 
formation, did not have such a drastic effect on NM aggregate induction, there 
has to be something special about SG inducing treatments. One explanation 
would be the redirection of the PQC system towards SG formation, while 
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disregarding and thereby enabling the aggregation of NM. For aggregation of NM 
to occur, recombinant NM fibrils need to be taken up and seed the aggregation of 
endogenous NM proteins. Once recombinant fibrils enter the cytoplasm they are 
most likely recognized as misfolded proteins by the PQC, which will initiate their 
degradation, and only fibrils that escape degradation can successfully induce NM 
aggregation. During stressful conditions the PQC would be busy assisting SG 
formation, neglecting the degradation of recombinant fibrils and permitting NM 
aggregation. Hence, the connection between SGs and protein aggregates might 
be different than hypothesized, in a way that rather the SG induction pathway 
than the presence of SGs is important. 
 
4.8 Relevance 
Several RBPs that harbor putative PrLDs and are part of SGs have already been 
implicated in degenerative disorders and recruitment of these RBPs to SGs has 
been hypothesized to facilitate their aggregation. However, the hypothesis that 
SGs are involved in disease pathology is mainly based on in vitro studies and 
evidence is still missing. Over the last years, research has focused on the idea 
that SGs evolve into pathological protein aggregates, but if SGs might be involved 
in the disease process in a different way was neglected. In our experimental 
setting, we were unable to turn NM sequestered by SGs into aggregates. 
Prolonged SG inducing treatment rather resulted in cell death, raising the 
question whether persistent SGs actually play a role in the disease process. The 
physical presence of SGs was not required for the increased aggregate induction 
by exogenous NM seeds, suggesting that the SG induction pathway and/or PQC 
could be involved in aggregate formation. Stress-inducible chaperones might be a 
key player in the first line of defense against protein misfolding upon stressful 
conditions. Sequestering aggregation-prone proteins in SGs could be a way of the 
cell to keep them under surveillance. However, exogenous triggers for protein 
misfolding, such as exogenous seeds, might overburden the PQC machinery 
under SG inducing conditions, facilitating protein aggregation. The spreading of 
protein aggregates from cell to cell, as it occurs in many neurodegenerative 
diseases, might benefit from the microenvironment during SG induction. The 
concomitant higher seeding efficiency would represent a risk factor for disease 
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pathology. Therefore, investigating the role of chaperones and the PQC in the SG 
induction pathway is crucial to understand a possible involvement of SGs in 
disease pathology. 
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Abbreviations 
 
% Percent 
°C Degree Celsius 
∆ Deletion 
aa Amino acid 
AD Alzheimer’s disease 
ALS Amyotrophic lateral sclerosis 
ATCC American type culture selection 
BSA Bovine serum albumin 
CNS Central nervous system 
conj. Conjugated 
CTN Carboxyterminal N domain 
DCP1a Decapping protein 1a 
DMEM Dulbecco's modified eagle's medium 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
E.coli Escherichia coli 
ECL Enhanced chemiluminescence 
EDTA Ethylenediaminetetraacetic acid 
eIF2α Eukaryotic translation initiation factor 2 alpha 
ER Endoplasmic reticulum 
et al. And others ('' et alia'') 
FCS Fetal calf serum 
Fig. Figure 
FRAP Fluorescence recovery after photobleaching 
FRMP Fragile X mental retardation protein 
FTLD Frontotemporal lobar degeneration 
FUS Fused in sarcoma 
g Gram 
G3BP Ras GTPase-activating protein-binding protein 
GCN2 general control non-depressible-2 
 Abbreviations 
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GFP Green fluorescent protein 
h Hour 
H2Obidest Bidistilled water 
HA Hemagglutinin 
HMW High molecular weight 
HRI Heme-regulated inhibitor 
HRP Horseradish peroxidase 
Hsp Heat shock protein 
IDR Intrinsically disordered region 
IF Immunofluorescence 
Ig Immunoglobulin 
IPTG Isopropyl-β-D-thiogalactopyranoside 
kDa Kilodalton 
Keap1 Kelch-like ECH-associated protein 1 
l Litre 
LB Lysogeny broth 
LC3 A/B Light chain 3 alpha/beta 
LCD Low complexity domain 
LMW Low molecular weight 
LLPS Liquid-liquid phase separation 
M Molar concentration 
mA Milliampere (10-3) 
mAb Monoclonal antibody 
min Minute 
ml Milliliter (10-3) 
mM Millimolar concentration (10-3) 
mRNA Messanger ribonucleic acid 
mRNP Messanger ribonucleoprotein 
N Asparagine 
N2a Murine neuroblastoma cell line 
ng Nanogram (10-9) 
nm Nanometer (10-9) 
NM NM domain of Sup35 
 Abbreviations 
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NMagg Aggregated NM protein 
NMsol Soluble NM protein 
ns Not significant 
OD Optical density 
OPR Oligopeptide repeat region 
pAb Polyclonal antibody 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PERK endoplasmatic reticulum-resident protein kinase 
PKR protein kinase R 
PQC Protein quality control 
PrD Prion domain 
PrLD Prion-like domain 
PrP Prion protein 
PrPC Cellular isoform of the prion protein 
PrPSc Pathogenic isoform of the prion protein 
PVDF Polyvinylidene difluoride 
Q Glutamine 
QNR Asparagine- and glutamine- rich region 
RBP RNA-binding protein 
RNA Ribonucleic acid 
RNP Ribonucleoprotein 
rpm Revolutions per minute 
RRM RNA recognition motif 
RT Room temperature 
S. cerevisiae Saccharomyces cerevisiae 
SD Standard deviation 
SDD-AGE Semi-denaturing detergent - agarose gel electrophoresis 
SDS Sodium dodecyl sulfate 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
sec Second 
SG Stress granule 
siRNA Small silencing RNA 
 Abbreviations 
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SOD1 Superoxide dismutase 1 
TBS Tris-buffered saline 
TBST Tris-bufferd saline, Tween-20 
TDP-43 43 kDa, transactive response DNA binding protein 
TIA-1 T-cell-restricted intracellular antigen-1 
TIAR TIA-1-related protein 
Tris Tris(hydroxymethyl)aminomethane 
TSEs Transmissible spongiform encephalopathies 
UV Ultraviolet 
V Volt 
VCP Valosin-containing protein 
WB Western blot 
µg Microgram (10-6) 
µl Microlitre (10-6) 
µm Micrometer (10-6) 
µM Micromolar concentration (10-6) 
